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 ABSTRACT 
 
         A cross sectional and prospective hospital based study in Elshaab 
Teaching Hospital (National Center For Neurological Science), 
Khartoum Teaching Hospital and Dr Gafaar Ibn Auf  Children's 
hospital. The duration of the study was from 1st of September 2005 
to the end of February 2007. 
       The objectives were to study the clinical presentations, causes 
and the imaging findings associated with the intracranial space 
occupying lesions. 
       The study included 103 children; male to female ratio was 
1.7:1. One third of children were below 5 years of age, 31% 
between 5-10 years and 35% were above 10 years. The study tools 
included questionnaire, clinical examination and investigations 
including brain C.T and MRI studies. 
         The commonest intracranial SOL was astrocytoma (35.0%), 
followed by abscess (19.4%) and medulloblastoma in (10.7%). 
          Headache was found to be the main presenting symptom 
occurring in (59.2%).Cranial nerves involvement was the 
 iv
commonest clinical sign detected in (43.7%) followed by gait 
disturbance detected in (42.7%) respectively. The commonest 
fundal change was papilloedema (18.5%).Most of lesions detected 
were supratentorial (72.8%) and they were found to be commonly 
benign in nature (54.7%), malignant lesions were confined mainly 
to infratentorial area (78.6%). 
       Malignant lesions affected males more than females (1.6:1). 
Ventricular dilatation was the common imaging finding detected 
in (46.7%). Malignant lesions (65.6%) needed V.P shunt operation 
more than benign lesions (35.0%). 
Congenital heart disease (4.8%) was a risk factor for brain 
abscess. 
Tuberculoma was detected less than expected (1.9%). 
        The main recommendations are: To consider headache and 
vomiting early warning signs, proper evaluation of children and 
use of CT and MRI to detect lesions early. Decentralization of 
services and training of general doctors and pediatricians.     
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  ﺹ ﺍﻷﻁﺭﻭﺤﺔﻠﺨﻤﺴﺘ
    
ﰲ ﻣﺴﺘﺸﻔﻴﺎﺕ ﺍﻟﺸﻌﺐ، ﺍﳋﺮﻃﻮﻡ ﺍﻟﺘﻌﻠﻴﻤﻲ ﻭﺟﻌﻔﺮ ﺑﻦ ﻋﻮﻑ ﻄﻌﻴﺔ ﺍﳌﺴﺘﻘﺒﻠﻴﺔ  ﺍﳌﻘﺃﺟﺮﻳﺖ ﻫﺬﻩ ﺍﻟﺪﺭﺍﺳﺔ 
ﻡ  ﻭﻗﺪ ﻛﺎﻥ ﻣﻦ ﺃﻫﺪﺍﻑ ﻫﺬﻩ 7002ﻡ ﺇﱃ ﺎﻳﺔ ﻓﱪﺍﻳﺮ 5002ﻟﻸﻃﻔﺎﻝ ﰲ ﺍﻟﻔﺘﺮﺓ ﻣﺎﺑﲔ ﺍﻻﻭﻝ ﻣﻦ ﺳﺒﺘﻤﱪ 
ﺍﻟﺪﺍﺭﺳﺔ ﻣﻌﺮﻓﺔ ﺍﻷﻋﺮﺍﺽ ﻭﺍﻟﻌﻼﻣﺎﺕ ﺍﳌﺼﺎﺣﺒﺔ ﻟﻶﻓﺎﺕ ﺍﻟﱵ ﺗﺸﻐﻞ ﺣﻴﺰﺍﹰ ﺩﺍﺧﻞ ﺍﻟﺘﺠﻮﻳﻒ ﺍﻟﺪﻣﺎﻏﻲ ﺑﺎﻹﺿﺎﻓﺔ 
  . ﺻﻮﺭ ﺍﻟﺮﻧﲔ ﺍﳌﻐﻨﻄﺴﲕ ﻭﺍﻷﺷﻌﺔ ﺍﳌﻘﻄﻌﻴﺔ ﰲﺇﱃ ﺍﳌﺴﺒﺒﺎﺕ ﻭﺍﻟﻌﻼﻣﺎﺕ ﺍﳌﺼﺎﺣﺒﺔ 
  .7.1:1 ﻣﺮﻳﺾ ﻭﻗﺪ ﻛﺎﻧﺖ ﻧﺴﺒﺔ ﺍﻟﺬﻛﻮﺭ ﻟﻼﻧﺎﺕ301       ﴰﻠﺖ ﺍﻟﺪﺭﺍﺳﺔ 
ﺳﻨﻮﺍﺕ 01 - 5ﻣﻦ ﺍﳌﺮﺿﻰ ﺃﻋﻤﺎﺭﻫﻢ ﺑﲔ % 13, ﺳﻨﻮﺍﺕ 5ﻣﻦ ﺍﳌﺮﺿﻰ ﺃﻋﻤﺎﺭﻫﻢ ﺍﻗﻞ ﻣﻦ %  43  
  .ﺳﻨﻮﺍﺕ 01ﻣﻦ ﺍﳌﺮﺿﻰ ﺃﻋﻤﺎﺭﻫﻢ ﺃﻛﺜﺮ ﻣﻦ % 53ﻭ
 ﻭﺍﻟﻔﺤﻮﺻﺎﺕ ﺍﳌﺨﱪﻳﺔ ﺇﺿﺎﻓﺔ ﻯ  ﴰﻠﺖ ﻭﺳﺎﺋﻞ ﺍﻟﺪﺭﺍﺳﺔ ﺍﺳﺘﺒﻴﺎﻥ ﻟﻠﻤﺮﺿﻰ ﺑﺎﻹﺿﺎﻓﺔ ﺇﱃ ﺍﻟﻜﺸﻒ ﺍﻟﺴﺮ ﻳﺮ
  .ﻟﻸﺷﻌﺔ ﺍﳌﻘﻄﻌﻴﺔ ﻭ ﺍﻟﺮﻧﲔ ﺍﳌﻐﻨﻄﻴﺴﻲ 
ﰒ % 4.91ﻳﻠﻴﻬﺎ ﺍﳋﺮﺍﺝ %  53 ﻭﺟﺪ ﺃﻥ ﺃﻛﺜﺮ ﻫﺬﻩ ﺍﻵﻓﺎﺕ ﺷﻴﻮﻋﺎﹰ ﻫﻲ ﻭﺭﻡ ﺍﳋﻼﻳﺎ ﺍﻟﻨﺠﻤﻴﺔ        
  %.7.01 ﺍﻟﻨﺨﺎﻣﻲ ﻰﺍﻟﻮﺭﻡ ﺍﻟﱪ ﻋﻤ
 ﻯﻭﻋﻨﺪ ﺍﻟﻜﺸﻒ ﺍﻟﺴﺮ ﻳﺮ%. 2.95   ﻛﻤﺎ ﺧﻠﺼﺖ ﺍﻟﺪﺭﺍﺳﺔ ﺑﺎﻥ ﺃﻛﺜﺮ ﺍﻹﻋﺮﺍﺽ ﺷﻴﻮﻋﺎ ﻫﻮ ﺍﻟﺼﺪﺍﻉ 
  .    ﺸﻲﻭﺟﺪ ﺃﻥ ﺃﻛﺜﺮ ﻋﻼﻣﺔ ﻫﻲ ﺇﺻﺎﺑﺔ ﺍﻷﻋﺼﺎﺏ ﺍﻟﺪﻣﺎﻏﻴﺔ ﺗﻠﻴﻬﺎ ﺇﺿﺮﺍﺑﺎﺕ ﺧﻄﻮﺓ ﺍﳌ
  %(.5.81)ﺑﲔ ﻛﺸﻒ ﻗﺎﻉ ﺍﻟﻌﲔ ﺃﻥ ﺃﻛﺜﺮ ﺗﻐﻴﲑ ﻫﻮ ﺍﻟﻮﺩﻣﺔ ﺍﳊﻠﻴﻤﻴﺔ 
،ﻭﻭﺟﺪ ﺃﻥ  ﺍﻵﻓﺎﺕ %7.45ﻭﻫﻰ ﲪﻴﺪﺓ ﰱ % 8.27      ﻭﺟﺪﺕ ﻣﻌﻈﻢ ﺍﻵﻓﺎﺕ ﻓﻮﻕ ﺧﻴﻤﺔ ﺍﳌﺨﻴﺦ 
ﺍﻵﻓﺎﺕ ﺍﳋﺒﻴﺜﺔ ﻇﻬﺮﺕ ﰱ ﺍﻟﺬﻛﻮﺭ ﺃﻛﺜﺮ ﻣﻦ ﺍﻹﻧﺎﺙ ﺑﻨﺴﺒﻪ  %.6.87 ﰲ ﺧﻴﻤﺔ ﺍﳌﺨﻴﺦ ﺖﺍﳋﺒﻴﺜﺔ ﻣﻌﻈﻤﻬﺎ ﲢ
  (.6.1:1)
ﻭﻗﺪ . ﺟﺪ ﺃﻥ ﺍﻻﺗﺴﺎﻉ ﺍﻟﺒﻄﻨﻴﲎ ﻫﻮ ﺍﻷﻛﺜﺮ ﺷﻴﻮﻋﺎﹰ ﰲ ﺍﻷﺷﻌﺔ ﺍﳌﻘﻄﻌﻴﺔ ﻭﺍﻟﺮﻧﲔ ﺍﳌﻐﻨﺎﻃﻴﺴﻲ ﻟﻠﻤﺦ      ﻭ
ﺍﱃ  ﻋﻤﻠﻴﺔ ﺗﺮﻛﻴﺐ ﺟﻬﺎﺯ ﺻﻤﺎﻡ ﺑﲔ ﺍﻟﺒﻄﲔ %( 6.56)ﺍﺣﺘﺎﺝ ﺍﻻﺗﺴﺎﻉ ﺍﻟﺒﻄﻨﲕ ﺍﳌﺮﺗﺒﻂ ﺑﺎﻵﻓﺎﺕ ﺍﳋﺒﻴﺜﺔ 
  %(.53)ﻭﺍﻟﱪﺗﻮﻥ ﺃﻛﺜﺮ ﻣﻦ ﺍﻵﻓﺎﺕ ﺍﳊﻤﻴﺪﺓ
ﻋﻠﻰ ﺣﺴﺐ ﺍﻵﻓﺎﺕ ﺍﻟﺪﻣﺎﻏﻴﺔ ( ﺃﺷﻌﺔ ﻣﻘﻄﻌﻴﺔ ﻭﺭﻧﲔ ﻣﻐﻨﺎﻃﻴﺴﻲ  ) ﺗﻮﺟﺪ ﺗﻐﲑﺍﺕ ﳐﺘﻠﻔﺔ ﰲ ﺍﻟﺘﺼﻮﻳﺮ ﺍﻟﺪﻣﺎﻏﻲ
  .
iv 
ﻭﻫﻢ ﺃﻛﺜﺮ ﻋﺮﺿﻪ ﻣﻦ ﻏﲑﻫﻢ % 8.4     ﻭﺟﺪ ﺃﻥ ﻧﺴﺒﺔ ﺍﻷﻃﻔﺎﻝ ﺍﳌﺼﺎﺑﻮﻥ ﺑﺘﺸﻮﻫﺎﺕ ﺧﻠﻘﻴﺔ ﰲ ﺍﻟﻘﻠﺐ 
  (.9.1)ﻟﻺﺻﺎﺑﺔ ﲞﺮﺍﺟﺎﺕ ﺍﳌﺦ ﻛﻤﺎ ﻭﺟﺪ ﺃﻥ ﺍﻟﺘﻮﺭﻡ ﺍﻟﺪﺭﱐ ﰲ ﺍﳌﺦ ﺍﻗﻞ ﳑﺎ ﻫﻮ ﻣﺘﻮﻗﻊ 
ﻮﺻﻴﺎﺕ ﺍﻟﻌﺎﻣﺔ ﺍﳍﺎﻣﺔ ﲤﺜﻠﺖ ﰲ ﺍﻟﺘﻌﺎﻣﻞ ﺍﳉﺎﺩ ﻣﻊ ﺃﻋﺮﺍﺽ ﺍﻟﺼﺪﺍﻉ        ﺧﺮﺟﺖ ﻫﺬﻩ ﺍﻟﺪﺭﺍﺳﺔ ﺑﻌﺪﺩ ﻣﻦ ﺍﻟﺘ
 ﻻﺳﺘﺨﻼﺹ ﺍﻷﻋﺮﺍﺽ ﻭﺍﻟﻌﻼﻣﺎﺕ ﺍﻷﻭﻟﻴﺔ  ﺍﳌﺼﺎﺣﺒﺔ ﻯﺍﻟﺘﺎﺭﻳﺦ ﺍﳌﺮﺿﻰ ﺍﻟﺘﻔﺼﻴﻠﻲ ﻭﺍﻟﻜﺸﻒ ﺍﻟﺴﺮ ﻳﺮ,ﻭ ﺍﻟﻘﻲ
ﺍﺳﺘﺨﺪﺍﻡ ﺍﻷﺷﻌﺔ ﺍﳌﻘﻄﻌﻴﺔ ﻭﺍﻟﺮﻧﲔ ﺍﳌﻌﻨﺎﻃﻴﺴﻰ ﻟﻠﻤﺦ ﻣﺒﻜﺮﺍﹰ ﻻﻛﺘﺸﺎﻑ ﺍﻵﻓﺎﺕ ﺍﻟﺪﻣﺎﻏﻴﺔ , ﻟﻶﻓﺎﺕ ﺍﻟﺪﻣﺎﻏﻴﺔ 
ﺗﺒﲎ ﻻﻣﺰﻛﺮﻳﺔ ﺍﳋﺪﻣﺎﺕ ﺍﻟﺼﺤﻴﺔ ﻋﻦ ﻃﺮﻳﻖ ﺗﻮﻓﲑ ﺧﺪﻣﺎﺕ ﺗﺸﺨﻴﺼﻴﺔ ﺇﻗﻠﻴﻤﻴﺔ ﻭﻛﺎﺩﺭ , ﻫﺎ ﺍﻷﻭﱃﰲ ﺃﻃﻮﺍﺭ
ﳐﺘﺺ ﻭﺗﺒﲎ ﺗﺪﺭﻳﺐ ﺍﺧﺘﺼﺎﺻﻲ ﺃﻃﻔﺎﻝ ﰲ ﺃﻣﺮﺍﺽ ﺍﳉﻬﺎﺯ ﺍﻟﻌﺼﱯ ﻭﺟﺮﺍﺣﺔ ﺍﳌﺦ ﻭﺍﻷﻋﺼﺎﺏ ﻭﺍﻟﺘﺸﺨﻴﺺ 
  .ﺍﻻﺷﻌﺎﻋﻰ
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ADH                   Antiduretic hormone 
  
AIDS                  Acquired immunodeficiency syndrome 
 
ALL                    Acute lymphocytic leukaemia           
 
AVM                  Arteriovenous malformation 
 
CNS                    Central nervous system 
 
CPA                    Cerebellopontine angle 
 
CT                       Computed tomography 
  
HC                       Hydatid cyst 
 
MRA                   Magnetic resonance angiogram 
 
MRI                     Magnetic resonance imaging 
 
NS                       Neuro-schistosomiasis 
 
PNET                  Primitive neuroectodermal tumour 
 
SOL                    Space occupying lesion 
 
TB                      Tuberculosis 
 
TBM                  Tuberculous meningitis 
 
VDRL                Veneral disease research labrotory 
 
V.P                     Ventriculoperitoneal 
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Chapter One 
 
1.INTRODUCTION AND LITERATURE REVIEW 
 
 
1.1. Definition: 
   
          The term intracranial space occupying lesion is generally used to 
identify any lesion, whether vascular or neoplastic or inflammatory in origin 
which increases the volume of intracranial contents and leads to a rise in the 
intracranial pressure (1).  
1.2. Classification of intra cranial space occupying lesions:  
I. Congenital:  Dermoid, Epidermoid, Teratoma. 
II. Traumatic:  Subdural and Extradural haematoma 
III. Inflammatory : Abscess, Tuberculoma, Syphilitic gumma, Fungal 
granulomas. 
IV. Parasitic : Cysticercosis, Hydratid cyst, Amebic abscess, Schistosoma 
japonicum. 
V.Neoplasms;  
a) Tumors arising from neural structures: Gliomas – astrocytoma, 
ependymoma, oligodendroglioma, germinoma, medulloblastoma. 
b) Tumors arising from appendages: Meningioma, schwannoma, 
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chondroma,osteoma. 
c) Pituitary lesions: Pituitary adenoma, Craniopharyngioma. 
d) Vascular lesions: Angioma, Hemangioblastoma, Papilloma of choroid 
plexus. 
e) Secondary neoplasms. 
 
1.3.Brain Tumours: 
          The term "brain tumours" refers to a mixed group of neoplasms 
originating from intracranial tissues and the meninges with degrees of 
malignancy ranging from benign to aggressive. Each type of tumour has its 
own biology, treatment, and prognosis and each is likely to be caused by 
different risk factors. Even "benign" tumours can be lethal due to their site in 
the brain, their ability to infiltrate locally, and their propensity to transform 
to malignancy. This makes the classification of brain tumours  difficult sand 
creates problems in describing the epidemiology of these conditions(2). 
1.3.1. Incidence and Distribution:  
          Malignant tumours of the brain are a rare occurrence accounting for 
approximately 2% of all cancers in adults. Approximately 4400 people are 
newly diagnosed with a brain tumour each year in the UK compared to over 
40000 women with breast cancer and approximately 25000 men with 
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prostate cancer. The overall annual incidence rate of all brain tumours is 7 
per 100000 population(2). 
          Brain tumours are second only to leukaemia as the most prevalent 
malignancy in childhood, and they account for the most common solid 
tumours at this age group, comprising 15–25% of all paediatric 
malignancies(1). Different proportions of histological subtypes are present in 
children compared to adults, with gliomas (approximately 40%) and 
medulloblastomas (approximately 25%) mainly arising infratentorially, with 
the remainder, germ cell tumours and craniopharyngiomas, occurring in the 
midline. There is a small peak in incidence in early childhood accounted for 
by medulloblastomas. Studies in the USA, Sweden, and the UK have 
reported what appear to be true rises in incidence over the last three decades 
which are unexplained by changes in diagnostic practice, treatment(2).   
Metastatic brain tumours are common in adults but relatively rare in 
children(3). A recent study by the National Cancer Institute shows that a 
significant increase in childhood brain tumours brings them the dubious 
distinction as the most common paediatric tumour.  
         In 1974, brain tumours occurred at an annual rate of 2.35 per 100,000 
children younger than 15 years, which increased to a corresponding value of 
3.45 in 1994. Similar changes in incidence were noted in ALL, which 
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showed a corresponding change in annual incidence from 2.74 to 3.33 per 
100,000 children younger than 15 years. This rise in brain tumour incidence 
among children is attributed to improved diagnostic methods and more 
awareness of brain tumours among physicians. However, environmental 
factors cannot be completely ruled out(4) .  
          The intracranial tumours of childhood differs  from the adult forms in 
term of distribution within the brain, histological characteristics and 
prognosis (5).They can present in many ways depending on the location, type 
and rate of growth of tumour and the age of the child(5).  
          In the study conducted by Abu Salih and Abdul Rahman the incidence 
of brain tumours in the Sudan in the period between 1971-1981 was 7% (123 
patients) of all neurosurgically admitted patients (1757 patients). They 
concluded that their series showed a high incidence of meningioma and very 
low incidence of acoustic neuroma compared to regional and international 
series (6) . Incidence of brain tumours in the Sudan as reported by Abu Salih 
and Abdul Rahman was as Follows(6): Menengiomas 45.5% , Gliomas  
39.8%, Pituitary adenomas  10.6%, Craniopharyngiomas   5.7%, Acustic 
neuromas  0.8% and metastatic tumours  6.5% . 
          Brain tumours were found to be more common in males (63.4%) and 
most commonly affect those in the third decade, followed by those in the 
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fourth decade(6). 
        Bella Ahmed Elsherif, studied the pattern of malignant disease in 
children presenting to Khartoum hospital during the period July 1982-
May1983 in one hundred children and he found that the age distribution was 
similar to other works for all forms of cancer, apart from the peak incidence 
of leukemia, which was above the age of 4 years, while in Western 
countries, it was reported to be between 2-4 years. The male preponderance 
in all forms of cancer. Lymphoma (25% of all forms of cancer), was the 
leading malignant disease. Leukemia was the fourth in rank order (13%).        
Wilms tumour ranked the second in his study (14%). The percentage of 
retinoblastoma in the study (11%) contrasted significantly with the paucity 
of this form of cancer elsewhere. Carcinoma nasopharynx(10%) was an 
other good example for such a discrepancy. Brain tumours ranked the 
seventh in his study (7%). Interestingly, some rare forms of cancer such as 
skin, liver and ovarian cancer, in Africa as well as Western series, have been 
found relatively prominent (2%) (7).  
        In Saudi Arabia, malignant astrocytoma accounts for 16% of all 
intracranial space-occupying lesions(8) and although patients harboring this 
tumour are being managed in most neurosurgical units all over the country 
published data from Saudi Arabia relating to the survival of patients with 
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malignant astrocytoma has been limited to one report which focused on 
malignant astrocytoma in children(8). 
         In Nairobi, Wanyoike reported that thirty seven children were treated 
for posterior fossa tumours between 1998 and 2003, twenty four were 
females while thirteen were males giving a male: female ratio of 1:1.8. The 
age varied between 2-16 years. Cerebellar symptoms were the most common 
mode of presentation (30%) followed by headaches and vomiting. Twenty 
percent of patients were blind at presentation probably due to chronic effects 
of raised intracranial pressure. Out of 11 patients with histological diagnosis 
of meduloblastomas, over 99%, were females and only one was a male. 
Astrocytomas were evenly distributed at five males and six females. 
Posterior fossa tumours in this study are more common in females than in 
males, M: F ratio of 1:1.8. Over 90% of medulloblastomas are found in 
female children making it a predominantly female tumour as opposed to 
available literature (9).  
        Mwang studied the frequency, mode of presentation and outcome 
following treatment of gliomas in patients treated at the Kenyatta National 
Hospital in Nirobi. Two hundred and fourteen histologically confirmed 
intracranial tumours were included. Ninety seven (45.8%) of these were 
gliomas of which eighty one were astrocytomas, ten ependymomas and six 
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oligodendrogliomas. Meningiomas were the next common tumours (34.4%). 
Gliomas affected the young age group most, with the peak in the first decade 
of life. Males were most affected with a male to female ratio of 1.4:1.     
Features of increased intracranial pressure were the commonest mode of 
clinical presentation. The parietal region was the commonest site of 
intracranial gliomas (37.5%) (10).  
        In India,  Desai reported that 102 patients under the age of 12 years 
with cerebellar astrocytomas were retrospectively analyzed. The clinical 
features were predominantly related to increase intracranial pressure and the 
location of the tumour. Twenty-six tumors were located in the vermis and 76 
in the cerebellar hemisphere. The brain stem was involved in 20 patients. All 
102 patients had a preoperative contrast-enhanced CT scan. Midline vermian 
tumors were predominantly solid and enhancing, whilst the hemispheric 
tumors were cystic and nonenhancing (11).  
  1.3.2. Risk factors: 
          Brain tumours develop as a consequence of accumulated genetic 
alterations that permit cells to evade normal regulatory mechanisms and 
destruction by the immune system. These alterations may be in part or 
wholly inherited but any agents—chemical, physical or biological—that 
damage DNA are possible neurocarcinogens(2). 
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  1.3.3. Genetics: 
          Genetic predisposition to developing brain tumours is associated   with 
certain inherited syndromes such as tuberous sclerosis, neurofibromatosis 
types 1 and 2, nevoid basal cell carcinoma syndrome, and syndromes 
involving adenomatous polyps. These syndromes account for 1–2% of all 
tumours. The Li-Fraumeni cancer family syndrome is also associated  with  a 
predisposition to brain tumours and specifically with mutations in the TP53 
gene. Mutations in constitutional (that is, non-tumour tissue) TP53 have been 
linked to patients with gliomas(2).  
         Familial aggregations of brain tumours occurring in different 
generations and sib ships occur very rarely and the patterns of inheritance are 
inconsistent. In these situations common environmental exposures cannot be 
excluded as an explanation. Overall, it appears that only a very small 
proportion of brain tumours can be due to the effect of inherited 
predisposition (11).  
  1.3.4. Immune factors: Viruses, Allergies & Infections: 
          In experimental animal models brain tumours can be induced by a 
number of viruses, including retroviruses, papovaviruses, and adenoviruses 
but there is little epidemiological support for this occurring in humans. At 
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one time it was thought that live polio vaccines contaminated with SV40 
might increase the risk of brain tumours, but this was not supported by more 
detailed powerful studies. Direct examination of brain tumour tissue for 
evidence of a viral cause has shown the presence of different viral DNA 
sequences in some cases within separate pathological series. However, the 
mechanisms of how a virus might initiate malignant transformation remain 
unknown (11). 
         Atopic diseases such as asthma, eczema, and allergies can be markers 
of immune dysfunction. In a number of independent studies from different 
countries atopic conditions have been shown to be "protective", particularly 
in the development of gliomas. Patients with gliomas report fewer symptoms 
of  atopy compared to control subjects (12).  
         In utero infections with influenza and chicken pox (varicella) have 
been cited as a risk factor but the case for this is not strong. Some recent 
epidemiological work on a series of children from the north west of England 
diagnosed with brain tumours has shown geographical distributions which 
are suggestive of an infectious aetiology for some of the tumour types (12). 
 1.3.5. Chemicals: 
          N-nitroso compounds are found in the environment but the most 
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common source of human exposure is through foods, with vegetables and 
cured meats being major sources. Alkylating agents, such as methyl 
nitrosurea, are known transplacental carcinogens, particularly for brain 
tumours in rats (11). 
1.3.6. Head trauma and injury: 
            Patients with brain tumours inevitably recall occurrences of trauma 
or injury to the head, and studies of patients’ reports are therefore subject to 
"recall bias". Some epidemiological investigations of the relation between 
head trauma/injury and the subsequent development of a tumour have 
attempted to overcome this by examining medical records, but these mainly 
fail to demonstrate any relation (12). 
1.3.7. Tumour types:  
          Molecular cytogenetic techniques have helped to understand that brain 
tumours arise from genetic disruptions in cells, causing the cells to become 
neoplastic, but the causes of genetic disruption remain unclear. Brain 
tumours in the same family members are extremely rare. Furthermore, brain 
tumours can occur anywhere in the intracranial space (13). The tumour is 
named according to the cellular origin and the microscopic appearance. Most 
childhood brain tumours arise in the supporting cells of the brain (glia) and 
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are called gliomas. The most common is the astrocytoma, derived from 
astrocytes, which are major supportive cells. Astrocytes constitute nearly 
40% of the total CNS cell population and are widely spread throughout the 
central nervous system including the optic nerves (13). The tumours are 
classified histologically from grade I through grade IV. Grade I and II are 
histologically benign, but grade III and grade IV are malignant, hence 
glioblastoma. Other tumours are ependymomas, gangliogliomas, choroid 
plexus papillomas, and oligodendrogliomas. Other common brain tumours in 
childhood arise in the primitive nerve cells, and are much more common in 
children than in adults (14). When they occur in the cerebrum, they are called 
“primitive neuroectodermal tumour (PNET). In the infratentorial location 
they are called medulloblastomas, while those in the pineal gland are called 
pineoblastomas. They are malignant, grow rapidly, and tend to spread 
through the CSF (14).  
        A third type of childhood brain tumour arises in the non-neuronal 
embryonal cells. They are germ cell tumours, craniopharyngiomas, or 
dermoids. Tumours arising in the meninges, nerve sheaths, or pituitary gland 
have an expansible nature with little or no infiltration to the brain or spinal 
cord. They are meningiomas, neurinomas, and pituitary adenomas 
respectively. They usually occur in adults, but can appear in children (15).  
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1.3.8. Brain tumours’ warning signs:  
            Space-occupying lesions such as brain tumours increase the 
intracranial pressure. This causes the brain structures to shift within the 
intracranial space, which may be life-threatening. Many childhood tumours 
are found in the skull midline, which often produces hydrocephalus. In such 
cases, hydrocephalus is the primary cause of symptoms rather than the 
tumour itself (4).  
         Initial symptoms are early morning intermittent headaches and nausea, 
lasting for several months or years. Then, the headaches become more 
frequent and intense with emesis accompanied by dizziness, weakness, 
unsteadiness, and double vision. Increasing sleepiness, gait disturbance, 
ocular changes (abducens palsy in particular), visual disturbance, seizures, 
tremors or weakness of the extremities are more definitive signs for 
childhood brain tumour. The presentation depends on age group, the 
tumour’s location and histology. Infants and younger children typically 
present with irritability and rapidly expanding head size. They may also 
present with failure to thrive or precocious puberty (4).  
           Papilloedema is another sign of hydrocephalus or a mass-induced rise 
in intracranial pressure. If papilloedema is persistent and untreated blindness 
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may result. Shifts of brain contents through the tentorial opening or the 
foramen magnum may occur, causing twisting and compression of the brain 
stem, leading to bradycardia, hypertension, and irregular respirations. Due to 
compression of the third nerve, the ipsilateral pupil is enlarged and does not 
react to the light, the patient exhibits changes in body and limb tone and 
posture (decortication and decerebration), and stops breathing(15).  
1.3.9. Diagnosis: 
           CT images show skull, blood clots, and the calcified mass which 
 appears white, while the brain is gray, and the CSF, fat and air appear black. 
Contrast dye injected intravenously enhances visualization of the blood 
vessels and most pathological conditions such as tumours. Thus, CT scan is 
capable of disclosing not only a tumour mass, its location and extension but 
also any associated pathological changes such as brain oedema around the 
tumour, hydrocephalus, hemorrhage, cystic formation, calcification, etc.  
The risks are the requirement of sedation for the young child, possible 
allergic reaction to the intravenous contrast dye, and radiation exposure. 
Published reports warn that more than 20 rads may cause later cataracts (11).  
          Magnetic resonance imaging (MRI), which involves a high-powered 
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magnet, became available in the mid 1980’s. MRI images allowing a more 
detailed examination than is possible with CT.   
          Due to the risks involved in standard angiography, MRA (magnetic 
resonance angiography) has replaced angiography in most situations (11).  
1.4. Intracranial abscesses:  
         Intracranial abscesses are uncommon, serious, life-threatening 
infections. They include brain abscess and subdural or extradural empyema. 
A high number of brain abscesses are polymicrobial (16). 
1.4.1. Epidemiology: 
       Brain abscesses are rare in developed countries but are a significant 
problem in the developing world; they occur more frequently in males and in 
those younger than 40 years old. A decrease in meningitis due to the 
Haemophilus influenzae vaccine has reduced the prevalence in young 
children. The prevalence of brain abscess is higher in patients with HIV 
infection (16). 
1.4.2. Pathology: 
         It begins with vascular seeding of the brain, producing early cerebritis 
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during the first 1-3 days. Inflammatory infiltrates of polymorphonuclear 
cells, lymphocytes and plasma cells follow within 24 hours. By 3 days the 
surrounding area shows a marked increase in perivascular inflammation. The 
late cerebritis phase develops approximately 4 to 9 days after infection 
during which time the centre becomes necrotic, containing a mixture of 
debris and inflammatory cells. Neovascularity is maximal at this time. Early 
reactive astrocytes surround the zone of infection and proceed to early 
capsule formation between approximately 10 to 13 days. At this time, the 
necrotic centre shrinks slightly and a well developed peripheral fibroblast 
layer evolves. The late capsule stage continues to evolve between 14 days 
and 5 weeks with continual shrinking of the necrotic centre and relative 
decrease in the inflammatory cells. The capsule thickens as reactive 
astrocytes proliferate (17). 
Causative organisms include: Bacteria: common bacterial causes include 
Staphylococcus aureus, Streptococci, Bacteroides species and Listeria.  
Fungi: Aspergillus, Candida, Cryptococcus, Coccidioides, Histoplasma, 
Blastomyces.  
Protozoa: e.g. Toxoplasma gondii, Entamoeba histolytica, Trypanosoma 
 
 16
 cruzi, Schistosoma.  
Helminths, e.g. Taenia solium.  
          The frequency of fungal brain abscess has increased because of the 
frequent administration of broad-spectrum antimicrobials, 
immunosuppressive agents, and corticosteroids. They can originate from 
infection of adjacent structures, e.g. otitis media, dental infection, 
mastoiditis, sinusitis. Abscess formation can also develop following blood-
borne spread from a remote site, e.g. in patients with cyanotic congenital 
heart disease, endocarditis, dental caries (18). In at least 20% of cases, no 
source can be identified. 
1.4.3. Presentation:  
          Symptoms of onset may be sudden or subacute over several weeks.  
Common presenting symptoms include fever, headache, changes in mental 
state (drowsiness, confusion), focal neurological deficits, seizures, nausea 
and vomiting, neck stiffness.  
        A suddenly worsening headache, followed by emerging signs of 
meningism, is often associated with rupture of the abscess (15).  
        The main signs include: fever, focal motor or sensory deficits, raised 
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blood pressure and bradycardia associated with raised intracranial pressure 
papilloedema, ataxia, confusion, drowsiness, bulging fontanelle in infants.  
1.4.4. Differential Diagnosis includes: 
Meningitis, encephalitis, brain tumour or other intracranial space occupying 
lesion.  
1.4.5. Investigations: 
Full blood count: marked leucocytosis. Raised ESR and CRP.  
Renal function and electrolytes: serum sodium levels may be lowered as a 
result of inappropriate antidiuretic hormone production.  
        At least two blood cultures should be taken and preferably before 
antibiotics are started.  
       Serological tests are available for some pathogens.  Lumbar puncture 
and CSF analysis is rarely helpful (unless required to rule out meningitis) 
and is contraindicated if increased intracranial pressure is present (15).  
CT scanning is the investigation of choice(15), although MRI scan provides 
greater contrast between cerebral oedema and the brain and early detection 
of satellite lesions .MRI is especially useful for posterior fossa 
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abscesses(16).In addition, MRI with intravenous gadolinium contrast is 
superior in demonstrating cerebritis surrounding oedema, the extent of the 
mass effect, or associated venous thrombosis. MRI with or without 
gadolinium is preferable to CT scan for demonstrating multiple lesions. The 
evolution of the abscess can be followed radiologically. In the early 
cerebritis stage, CT images reveal a low density lesion with ring 
enhancement. In the late cerebritis and early capsule stage, well-formed, ring 
enhancement is typically thin walled and uniform or nodular enhancement 
should raise the possibility of an alternative cause. Delayed contrast scans 
show diffusion of the contrast. Other ring enhancing lesions that may mimic 
the image of the brain abscess include primary and metastatic tumour, a 
resolving infarct or haematoma and rarely demyelinating disease (17). 
Other investigations include, aspiration of abscess for culture and  
biopsy of cerebral lesion.  
1.4.6. Management: 
        Early treatment with antimicrobial therapy, anticonvulsant therapy and 
measures to control increasing intracranial pressure is essential.  
Initial antimicrobial therapy should be started immediately and then 
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modified according to the results of cultures.  Initial therapy choices include 
high doses of penicillins, metronidazole, either gentamicin or 
chloramphenicol, vancomycin, meropenem and cephalosporins (e.g. 
cefotaxime). If fungal cause is suspected then amphotericin, flucytosine 
fluconazole or voriconazoleare indicated. The treatment of choice for 
toxoplasmosis is a combination of pyrimethamine and sulfadiazine.  Therapy 
should be given intravenously for at least the first week. Corticosteroids: 
intravenous dexamethasone is used if massive cerebral oedema is seen on 
the CT scan (17).  
         Once an abscess has formed, surgical excision or drainage through a 
burr hole, combined with prolonged antibiotics (usually 4-8 weeks), remains 
the treatment of choice.  
       Aspiration is the most common procedure and is often performed using 
a stereotactic procedure with the guidance of CT scanning or MRI. 
Craniotomy is generally performed in patients with larger, multiloculated 
abscesses and for those whose conditions failed to resolve.  
       Management of subdural or epidural empyema requires prompt surgical 
evacuation of the infected site and antimicrobial therapy (17).  
          Mawang in Nairobi studied the aetiology, mode of presentation and 
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outcome following treatment of brain abscesses.  Sixty five patients with 
brain abscesses were seen at Kenyatta National Hospital. There were more 
male patients than females (ratio 2.4:1). Thirty eight per cent of the patients 
were children below the age of ten years. Trauma was the commonest cause 
of brain abscess. The aetiology was unknown in 24% of the cases. Sixty 
eight per cent of the patients had seizures. All the patients were diagnosed 
by computerised tomography (CT) scanning (18). 
 
1.5. Tuberculosis: 
 
1.5.1. Epidemiology:  
          About 2000 million people in the world today are infected with 
tuberculosis,(19) but only 10% develop clinical disease. In 2002 
approximately 15,000 new cases of TB disease were diagnosed in the United 
States. Of these, 6% were among children aged <15 years (20). Although the 
number of cases in this age group has been decreasing since 1992, the 
number co infected with HIV is uncertain because only a limited number of 
U.S. children who have TB have been tested for HIV infection. Close 
correlation exists between the observed incidence of TBM in children aged 
0-4 years, and the population's annual average risk of infection with M 
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tuberculosis. The incidence of TBM has been calculated to represent 1% of 
the annual risk of infection (21). The total number of tuberculosis cases in the 
world is increasing (22).It is estimated that most of these new cases will be in 
south east Asia (23) fuelled by the rapid spread of HIV. It has been predicted 
that without intervention 200 million people alive today will develop TB (24).  
        An estimated Annual Risk of infection (ARI) of 1.8% which gives an 
incidence of 90/100,000 smear positive cases puts Sudan among the high 
prevalence countries for TB in the East Mediterranean Region (25). 
        The Sudan National Tuberculosis Programme (NTP) declared DOTS 
all over in January 2002. The years 2004, 2005(of 70% case detection and 
85% cure rate) (26).Percentage of admission with TB from all inpatients was 
1.0% in 2000, and 0.6% in 2004. In addition, the percentage of death due to 
the disease of admission: 11.2% in 2000, and 10.5% in 2004(27). 
        Mustafa Sid Ahmed studied the clinical pattern of intracranial space 
occupying lesion in adults during the period 1998-1999 in 118 patients in 
Sudan, and he found that tuberculoma represented (8.5%) (28).  
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1.5.2. Causative agent:  
         Tuberculous meningitis was first described as a distinct pathological 
entity in 1836,and Robert Koch demonstrated that tuberculosis was caused 
by Mycobacterium tuberculosis in 1882(29).M tuberculosis is an aerobic gram 
positive rod that stains poorly due to its thick cell wall containing lipids, 
peptidoglycans, and arabinomannans. The Ziehl-Neelsen stain uses the 
properties of the cell wall to form a complex that prevents decolourisation by 
acid or alcohol (30).  
1.5.3. Pathogenesis: 
           The development of TBM is a two step process (31); M tuberculosis 
bacilli enter the host by droplet inhalation, the initial point of infection being 
the alveolar macrophage. Escalating localized infection within the lung with 
dissemination to the regional lymph nodes produces the primary complex. 
During this stage there is a short but significant bacteraemia that can seed 
tubercle bacilli to other organs in the body. In those who develop TBM 
bacilli seed to the meninges or brain parenchyma, forming small subpial or 
subependymal foci. These are called Rich foci, after the original pathological 
studies of Rich and McCordick(31). In about 10% of cases, particularly in 
children, the primary complex does not heal but progresses. Tuberculous 
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pneumonia develops with heavier and more prolonged tuberculous 
bacteraemia. Dissemination to the CNS is more likely, particularly if miliary 
TB develops. The second step in the development of TBM is rupture of a 
Rich focus into the subarachnoid space. This heralds the onset of meningitis 
which if left untreated, will result in severe and irreversible neurological 
pathology. In 75% of children the onset of TBM is less than 12 months after 
the primary infection (32).A rare complication of TBM is tuberculous 
encephalopathy. Usually occurring in a young child with progressive 
primary TB, the presentation is of reducing conscious level with few focal 
signs and minimal meningism. Diffuse oedema and white matter pallor   with 
demyelination are found pathologically. The pathogenesis is uncertain, but is 
presumed to be immune mediated (33). 
1.5.4. Clinical Features: 
         Recent contact with tuberculosis should be elucidated: several studies 
have shown that between 70% and 90% of children have had recent contact 
with TB (34). The prodrome is usually non-specific with no one symptom 
predominating: 28% report headache, 25% were vomiting, and 13% had 
fever (35). Only 2% reported meningitic symptoms.  
       In a review of 205 children only 38% had fever at presentation with 9% 
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reporting photophobia (35). 14% remained free from meningism throughout 
the illness. Recent reviews confirm the wide variety of presentations seen 
with TBM (36). 
         An Australian series of 58 patients found that on the day of admission 
TBM was considered a diagnosis in 36% of cases, with 6% receiving 
immediate treatment (34). The duration of presenting symptoms varied from 
1 day to 9 months, although 55% presented with less than two weeks of 
symptoms. 
        Adhesions can result in cranial nerve palsies (particularly II, III, IV, VI, 
VII, and VIII), constriction of the internal carotid resulting in stroke, and 
obstruction of CSF flow leading to raised intracranial pressure, reduced 
conscious level, and hydrocephalus. Infarcts occur in about 30% of cases (37) 
commonly in the internal capsule and basal ganglia, causing a range of 
disorders from hemiparesis to movement disorders. Seizures are common, 
especially in children and elderly people. Hydrocephalus, tuberculoma, 
oedema, and hyponatraemia due to inappropriate ADH secretion can all 
cause seizures (38). 
       Over the past 10 years there have been studies documenting the relation 
between HIV and TBM. Although HIV infected patients with TB are at 
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increased risk of TBM, (39) the clinical features and outcomes of the disease 
do not seem to be altered (40). Those with TBM and HIV often have 
concomitant extrameningeal disease. In one report 65% had clinical or 
radiographic evidence of extrameningeal TB on admission (39). In another 
series 77% of those with HIV had clinical evidence of extrameningeal TB 
compared with 9% in those without HIV(38).In more than half there may also 
be a CNS tuberculoma(41) .These distinguishing characteristics may facilitate 
the diagnosis of TBM in those with HIV.  
1.5.5. Diagnosis: 
         Newer methods such as those involving the amplification of bacterial 
DNA by the polymerase chain reaction (PCR) and comparable systems are 
incompletely assessed, and are not suitable for widespread use in the 
developing world. The careful and repeated search for acid fast bacilli with 
Ziehl-Neelsen staining is still one of the most effective rapid diagnostic tests. 
A history of recent TB contact is helpful (35) as is the presence of 
extrameningeal TB (42). Tuberculin testing is of limited value. Early studies 
found 22% of those with TBM were negative to 100 units PPD (43) .A recent 
study demonstrated cumulative reactivity with 10-100 units PPD to be 
75%(35) .Some studies suggest that tuberculin testing may be more useful in 
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children, with 86% having greater than 15 mm of induration with 5 units 
purified protein derivative (PPD) (36).Abnormalities in the CSF depend on a 
tuberculin reaction within the subarachnoid space. Those with depressed cell 
mediated immunity may have atypical findings in the CSF. Acellular CSF in 
elderly and HIV positive patients have been reported(38) .Lymphocytosis of 
between 100 and 1000 cells/mm3 is more usual, although in the first 10 days 
polymorphonuclear leucocytes may predominate(44). A raised CSF protein 
occurs in most, and CSF glucose will be reduced in 70% (39). 
          Both CT and MRI of the brain will disclose hydrocephalus, basilar 
meningeal thickening, infarcts, oedema, and tuberculomas. In a CT study of 
60 cases of TBM in adults and children only three had normal brain scans(45). 
Hydrocephalus was reported in 87% of children and 12% of adults. The 
incidence of hydrocephalus is greater in the young, and increases with 
duration of the illness. In children hydrocephalus is almost always present 
after 6 weeks of illness (46). Infarcts are seen on CT in 28%, with 83% 
occurring in the middle cerebral artery territory. The basal ganglia are the 
most commonly affected region.  
        Both CT and MRI are sensitive to the changes of TBM, particularly 
hydrocephalus and basal meningeal exudates, but they lack specificity (46). 
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        The challenge facing new diagnostic strategies in TBM is that they 
must improve on the sensitivity of conventional Ziehl-Neelsen staining and 
culture, but maintain the specificity.  
        Adenosine deaminase is produced by lymphocytes and monocytes. Its 
detection in CSF has been reported with variable success, with sensitivities 
and specificities as high as 99% being suggested (47). 
        Serological techniques that detect the intrathecal synthesis of 
antimycobacterial antibodies have been studied (47). 
        The advent of DNA amplification techniques such as PCR has turned 
attention away from serological techniques. 
 
1.6. Schistosomiasis: 
             Schistosomiasis associated with Schistosoma mansoni infection is 
endemic in the Caribbean islands, the Middle East, South America, and 
Africa and may be imported to any other area in the world via immigration 
and travel to foreign lands. It is estimated that between 200 and 300 million 
people are infected by S. mansoni worldwide (48). In Brazil, it is estimated 
that between 10 and 12 million people have schistosomiasis mansoni(49). 
Spread of the disease from rural to peri-urban regions has been recently 
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described (49). The infection is localized in the digestive system, but the 
nervous system is the second most common involved site (50). Pittella& 
Lana-Peixoto recorded that ova were found in the brain of 26% of patients 
who have hepatosplenic S. mansoni infection. A study in Tanzania indicated 
that 6% of non-traumatic myelopathies in endemic areas may be attributable 
to schistosomiasis (51). 
         In Sudan: A study was conducted in Southern Sudan to determine the 
prevalence of intestinal parasites among school children. A total of 275 stool 
sample were examined. Hookworm with a prevalence of (13.1%) was the 
predominant nematode followed by S. Mansoni (2.2%) (52). 
       Amir Eltayeb studied the prevalence of intestinal protozoa and parasites 
infestations among under five children in Jabel Aweleia Governorate in 390 
patient in the period September 2003 to September 2004 and he found that 
schistosoma mansoni was found in 1 (0.3%) from the rural area (53) . 
       A parasitological survey of refugees based in Juba, involving 241 faecal 
samples,revealed that S. mansoni is the most prevalence(52%) among older 
teenagers , S. stercoralis shows (44%) in the five to nine-year old group(54)  . 
1.6.1. Pathogenesis: 
          Neuroschistosomiasis (NS) occurs when ova and or adult worms reach 
the central nervous system (CNS). Two mechanisms have been postulated 
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for this process: the ova are carried to the CNS through arterial or retrograde 
venous blood flow via the valveless perivertebral plexus of Batson, being 
deposited anywhere along the path of the blood flow, or the ova are 
deposited in situ after the anomalous migration of adult worms(55).  
          NS can be present in the early stages of the infection, while the patient 
is still asymptomatic, during the slow and gradual evolution of the disease to 
its chronic forms, or concomitantly with the chronic intestinal 
hepatointestinal or hepatosplenic forms (56). In the early post infective stage 
especially in non-immune subjects, neurological symptoms may 
occasionally appear in the Katayama syndrome which is attributed to an 
immunological reaction to cercariae or schistosomula or ova (57). 
         The granulomatous reaction of the host to the presence of the ova is the 
major immune response to the antigens released from the ova and is at a 
maximum intensity in the early stages of infection, leading to the formation 
of necrotic-exudative granulomas and the immune response declines over 
the course of the infection (58).  
1.6.2. Clinical syndromes: 
             The asymptomatic form of NS is more common than the 
symptomatic ones (59).   
            Clinical manifestations of cerebral NS include seizures associated 
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with an increase in intra-cranial pressure and focal CNS signs, depending on 
the site of the cerebral lesion, caused by the masses produced by the 
granulomas(60). Headache, papilloedema, visual abnormalities, speech 
disturbances, nystagmus and ataxia are common manifestations (59). Duration 
of the symptoms varies from a few weeks to more than one year (61).  
Different form of presentation: acute encephalitis or encephalomyelitis 
together with or immediately after the systemic manifestations of the acute 
phase, which include fever, headache, malaise, anorexia, coughing, skin 
rash, diarrhoea and abdominal pain (Katayama syndrome)(59); patients may 
become confused, develop focal or generalized seizures or become stupors 
and visual impairment and papilloedema may occur; signs of 
encephalopathy such as hemiplegia and opisthotonus with extensor plantar 
responses or evidence of myelopathy such as ataxia, weakness of the legs, 
paraesthesiae, sensory loss and sphincter disturbances may also occur(62).  
1.6.3. Diagnosis: 
          CSF in NS, which includes lymphomononuclear hypercellularity 
associated with the presence of eosinophils, an increase in protein 
concentration, and the presence of antibodies to S. mansoni. 
Habeebulla&Ross have recently reported a case of NS presenting with 
eosinophilic meningitis (63).  
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           Serologic techniques have been used but none have yet achieved 
sufficient levels of sensitivity and specificity to justify their consideration as 
gold standard techniques (64).  
 CT/MRI findings of cerebral schistosomiais have been described as single 
or multiple hyperdense lesions with variable enhancement surrounded by 
low-density oedema with an associated mass effect(65), that is a punctuate 
enhancement and a heterogeneous internal structure which correlates with a 
moderately large granuloma due to the presence of a collection of eggs(66).                         
Definitive diagnosis of NS is based on the demonstration of eggs and or 
adult worms in the CNS tissue (67). 
 
1.7. Arachnoid cysts : 
         Arachnoid cysts are non-tumorous intra-arachnoid fluid collections 
that account for about 1% of all intracranial space-occupying lesions (68). 
They may develop throughout the cerebrospinal axis, with a predominance 
in the sylvian region (69). Because of their benign nature and slow expansion 
arachnoid cysts may remain a symptomatic or produce only subtle 
symptoms and signs,  sometimes give rise to focal neurological deficits, 
raised intracranial pressure, and/or epileptic seizures.  
         The arachnoid cyst wall is histologically indistinguishable from normal 
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arachnoid membrane, moderate thickening of the arachnoid and increase in 
connective tissue is common (70).  
         In about 15% of middle fossa arachnoid cysts, an asymptomatic lesion 
may become symptomatic as a result of bleeding in association of the cyst 
and raised intracranial pressure. Treatment is by cystoperitoneal shunt after 
evacuation (71). 
 
 
1.8. Dermoid and epidermoid cysts: 
   
          Dermoid and epidermoid cysts are rare space-occupying lesions of the 
central nervous system. Although characterized by a slow growth rate, they 
are often associated with serious complications. Surgery is the only effective 
treatment, and radical resection of the entire cyst, whenever possible 
generally succeeds in achieving a cure (72). In dermoid cysts occurring during 
adulthood, symptoms and signs more clearly indicate a dysfunction of the 
posterior fossa. It is particularly important to establish the presence and type 
of communication of cysts with the CSF pathways. Although infratentorial 
cysts often communicate, they can be space-occupying masses because of 
increasing CSF retention, which may be due to a ball-valve mechanism or to 
inadequate communication. The frequently associated hydrocephalus, can be 
due to mechanical factors (73). 
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1.9. Toxoplasmosis:  
           Toxoplasma gondii is a protozoon that commonly affects mammals 
and birds throughout the world. Toxoplasma gondii infection in humans is 
usually asymptomatic. 
1.9.1. Epidemiology: 
          The major mode of transmission of Toxoplasma gondii infection 
among infants and young children is congenital. The incidence of congenital 
toxoplasmosis in the United States is an estimated one case per 1,000--
12,000 live-born infants (74) and is believed to have decreased substantially 
during the preceding 20 years. Older children, adolescents, and adults 
typically acquire Toxoplasma infection by eating poorly cooked meat that 
contains parasitic cysts or by ingesting sporulated oocysts in soil or 
contaminated food or water. 
1.9.2. Clinical Manifestations:  
          In studies of non immunocompromised infants with congenital 
toxoplasmosis, the majority of infants (70%-90%) are asymptomatic at birth; 
however, the majority of asymptomatic children develop late sequelae (e.g., 
retinitis, visual impairment, and intellectual or neurologic impairment) with 
the interval until the onset of their symptoms ranging from several months to 
years. Symptoms can include maculopapular rash, generalized 
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lymphadenopathy, hepatosplenomegaly, jaundice, hematologic 
abnormalities including anemia, thrombocytopenia and neutropenia, and 
substantial CNS disease, including hydrocephalus, intracerebral 
calcification, microcephaly, chorioretinitis, and seizures(75). 
1.9.3. Diagnosis: 
          Serologic testing is the major method of diagnosis, isolation of 
organisms, and PCR. 
         A presumptive diagnosis of CNS toxoplasmosis is based on clinical 
symptoms, serologic evidence of infection, and the presence of a space-
occupying lesion on imaging studies of the brain. Cases of Toxoplasma 
encephalitis have been reported in persons without Toxoplasma-specific IgG 
antibodies; therefore, negative serology does not exclude that diagnosis. 
Computerized tomography of the brain might indicate multiple, bilateral 
ring-enhancing lesions in CNS toxoplasmosis, especially in the basal ganglia 
and cerebral corticomedullary junction (76). Magnetic resonance imaging is 
more sensitive and will confirm basal ganglia lesions in the majority of 
patients. F-fluoro-2-deoxyglucose-positive emission tomography can be 
helpful in distinguishing toxoplasma abscesses from primary CNS 
lymphoma, but the accuracy is not high and this test is not widely 
available(77) .  
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1.10. Hydatid disease: 
      
 
            Hydatid disease is caused by larvae of cestodes of the genus 
Echinococcus, the adult of which is found in carnivores, which are the 
definitive hosts. The intermediate hosts are infected by swallowing eggs 
passed in the faeces of the definitive host. Two main forms of hydatid 
disease occur in man (78).  
1.10.1. Geographical distribution: 
          The most extensive and endemic areas of human infection are found in 
the sheep raising countries; South Australia, New Zealand, Tasmania, parts 
of North, South and East Africa the southern half of the south America. In 
addition human infection is frequently found in south-west states of the 
USA, Southern and Eastern Europe, Iraq, Syria, Lebanon, Turkey, 
Mongolia, Turkistan, North China, Southern Japan and North Vietnam(79). 
1.10.2. Incidence: 
         Amongst 1802 patient in Australian hydatid register, hydatid disease of 
the brain was found in 1 %( 80). According to another source it occurs in 2% 
of patients with hydatid disease (12). In reported series of hydatidosis, the 
chance of brain hydatid cyst has been between 1 to 3% (81), and it comprises 
about 0.02-2% of space occupying lesions of the brain (82). The human brain 
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can be involved primarily via the haematogenous route or by metastatic 
spread when a cyst ruptures in the heart or lung. The majority of the hydatid 
cysts in the brain are single (83). About 50-75% of intracranial hydatid cysts 
are seen in children (84). This high incidence in children is probably related to 
patent ductus arteriosus(85). Most cysts are supratentorial(87). Infratentorial 
HC is very rare (86). The other less common sites reported are skull  
cavernous sinus eyeball, pons, extradural, cerebellum and ventricles(87).  
       The hydatid cyst has a wall composed of two layers: an inner layer of 
germinal epithelium (endocyst), and an outer layer of laminated hyaline 
membrane (ectocyst), the ectocyst is striated and nonnucleated, and the 
endocyst is granular, nucleated, and friable. In most parts of the body, the 
host reacts to the presence of this alien organism by enveloping it in a 
fibroblastic capsule (adventitial membrane), but in the brain this membrane 
hardly develops (88). The fluid in the cyst is colourless and has a low specific 
gravity (1005-1015). The albumin content is 2 to 2.5 g/L, the glucose 
content is 0.30 to 0.50 g/L, and the chloride content is 6.49 g/L. Some 
lymphocytes, scolices, and hooks are also present in each milliliter of the 
fluid (89). 
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1.10.3. Clinical Features: 
           Generally are those of space occupying lesion and hydatid 
involvement of the brain is marked by slow mass effect, hydrocephalus and 
often seizures, occasionally metastatic lesions in the brain are the first to 
cause symptoms by local inflammation or mass effect(90). 
1.10.4. Diagnosis: 
          Thirty percent may show eosinophilia. Confirmatory evidence of 
infection may be obtained by serology.  
        The appearances of hydatid cysts in CT scan are cystic, spherical with a 
sharp border, a central absorptive value similar to CSF, and no perifocal 
oedema and usually with significant ventricular distortion and a shift of 
midline structures. There is lack of enhancement and of the perifocal 
oedema seen in cystic tumours(90) .  
 
1.11. Mycetoma: 
            Mycetoma is a chronic, localized subcutaneous infection 
characterized by draining sinus tracts, that containing granule. The disease 
most often affects the lower extremities with the majority of cases involving 
the foot. The organisms are usually introduced by a thorn. Rare sites such as 
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eye lids, testis, mandible, paranasal sinus, head and neck and spine has also 
been described. Neurological deficits are quite rare and less well 
described(16). 
          In the study conducted by Arbab, Idris, Sokrab et al, in nine cases 
comprising seven males and two females, they mentioned that the 
commonest causative organism was streptomyces somaliensis(66.7%).Males 
were affected more often than females(22.2%) and the source of infection 
was unknown in the majority of cases and only known in (33.3%)of cases.        
The most common mode of presentation was headache and scalp swelling 
(88.9%) the next common presentation was epilepsy (55.6%).Other focal 
neurological disorders such as hemiplegia and cranial nerve affection were 
also found. CT findings of the cranium showed osteosclerotic rather than 
osteolytic changes. They concluded that mycetoma of the cranium may 
present with various neurological disorders and may stimulate cerebral 
neoplasm or psudotumour cerebri(91). 
  
 
1.12. Aneurysms and arteriovenous malformations: 
 
 
          Aneurysm: Is widening of a vessel involving the stretching of fibrous 
tissue within the media of the vessel (16).These can be classified 
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morphologically into saccular, fusiform or mycotic. The pathogenesis of 
saccular aneurysms reflects a combination of congenital, acquired and 
hereditary factors. A modest increase in incidence of familial saccular 
aneurysms as well as their association with polycystic kidney disease, Ehler 
Danlos Syndrome and other connective tissue disorders implicate hereditary 
factors(16). 
          Fusiform aneurysms: spindle shape dilatation and elongation that 
occur in large arteries, most frequently in the basilar artery, which can 
compress cranial nerves v, vii, viii causing facial pain hemifacial spasm and 
hearing loss with vertigo respectively. Fusiform aneurysms may imitate the 
features of CPA angle tumours, or they mimic pituitary and suprasellar mass 
lesions. 
         Mycotic Aneurysms: Caused by septic degeneration of arterial wall 
muscle and elastic tissue .They form in distal cerebral arteries at the point 
where small septic cardiogenic emboli lodge. They are frequently multiple 
and can be found in anterior or posterior cerebral circulation 
1.12.1. Clinical Features: 
        A part from those related to subarachnoid haemorrhage due to rupture 
of aneurysm, it may present with features of space occupying lesion. 
       Bien SM,Thorn K and Hassler W , mentioned that CT diagnosis of 
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cerebral aneurysm is possible. In nonthrombosed giant aneurysm, CT shows 
a homogenous, primarily hyperdense space occupying lesion with 
enhancement. The partially thrombosed giant aneurysms appear hyperdense 
with hypodense or isodense portion in the plain CT scan  .CT scan diagnosis 
is possible in every case of partially or non thrombosed aneurysm ,but 
cerebral angiography remains the definitive study to detect the lesion(92) . 
1.12.2. Vascular malformation: 
Venous angioma: The most common type, usually lie close to the surface of 
the brain, seldom produce seizures or headache. 
Acerebral varix: is a single dilated vein and very rarely causes clinical 
symptoms. 
Telangectasia: Are common, they are usually located deep in the brain and 
rarely produce symptoms. Because of their location, haemorrhage from 
small vessels can occasionally be fetal. 
Cavernous angiomas: Are large sinusoidalchannels which can be 
thrombosed. They are readily detected by CT scan and rarely bleed, but they 
may cause headache and seizures (16). 
Arteriovenous malformation: The most common symptomatic vascular 
anomaly. Familial causes are rare, indicating that the problem reflects 
sporadic abnormalities in embryologic development. 
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1.12.3. Diagnosis:  
        By CT scan and MRI. Angiography remains the definitive test to 
identify the AVM and delineate its feeding arteries and draining veins (16). 
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? JUSTIFICATIONS 
 
 
 
 
• Intracranial SOLs is a serious problem in any children. 
• Early detection of symptoms and signs of intracranial SOLs can 
give better chance for treatment. 
• No similar study was done in children in Sudan. 
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? OBJECTIVES 
  
 
The study aims to study the:  
 
1.  clinical presentations of intracranial SOLs. 
 
2.   causes of intracranial SOLs in children. 
 
3.  imaging findings associated with intracranial SOLs. 
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Chapter Two  
2. MATERIALS AND METHODS  
  2.1. Study design:  
        It is a combined cross sectional and prospective hospital based study. 
2.2. Study Area:  
The study was conducted in Elshaab Teaching Hospital(National Center For 
Neurological Sciences),Khartoum Teaching Hospital and Dr Gafaar Ibn Auf 
Children's Hospital. 
2.3. Study Duration:  
        The study was done during the period from 1st September 2005 to end 
of February 2007. 
2.4. Study Population and Sampling Technique:  
2.4.1. Study Population: 
The study population included 103 children less than 18 years of age, 63 
males and 40 were females. 
2.4.2. Sampling technique:  
          The sample is an inclusive sample with no selection. All children who 
diagnosed as having intracranial SOLs after confirmation by brain CT scan 
or MRI admitted or seen in referral clinics in Elshaab Teaching Hospital 
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(National Center For Neurological Sciences) in Mondays and Thursdays ,or 
admitted in the selected hospitals during the study period were included .  
2.5. Inclusion criteria:  
       All children presenting with intracranial SOLs below 18 years old and 
new cases in the selected hospitals. 
2.6. Exclusion criteria: 
• Refusal to give consent for inclusion in the study by the parents or 
caretakers. 
• Patients with intracranial haemorrhage and or subdural haematoma 
were not included (because most of these cases are due to trauma). 
2.7. Methods  
2.7.1. Study Tools and Technique: 
a: Questionnaire:   
       A standardized questionnaire was used to obtain information concerning  
 personal history of the child, detailed history about the presenting 
complaint, symptoms of raised intracranial pressure, mental symptoms such 
as coma, sensory and motor symptoms, symptoms related to the cranial 
nerves. Past medical history of chronic cough, trauma to the head, 
schistosomaisis and epilepsy, family history and socioeconomic information.  
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b: Clinical examination: 
            Every child was subjected to a thorough clinical examination   
including a general check up for pallor,cyanosis, jaundice; chest was 
examined for evidence of congenital heart disease, also abdominal 
examination for organomegaly, generalized lymphadenopathy and proper 
C.N.S examination including fundoscopy, some difficult cases were reffered 
to the ophthalmologist. 
             All children had anthropometric measurements including skull 
circumference, height and weight.  
 2.7.2. Investigations:  
Routine investigations: 
           CBC, ESR, urea and electrolytes, x-ray of the skull ,x-rays of other 
parts of the body are ordered if secondaries were suspected. 
Investigations essential for diagnosis of intracranial SOL: 
           All patients had an MRI or brain CT scan to confirm the presence of  
 SOL. 
 
 Specific investigations:     
           Mantoux test, sputum for AAFB, chest x-ray, abdominal U/S and 
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 pituitary hormones were done in selected patients. 
 Other investigations: 
             Biopsy- histological confirmation of the lesion was obtained in those 
who   had access to surgery. 
2.8. Data Analysis: 
          The questionnaire was pre-coded, and a master sheet was constructed 
to arrange the raw data. Tables were drawn and descriptive statistics were 
measured. 
          Data was entered into SPSS (statistical package for social science) 
computerized program for analysis, and Chi-square test was then used to 5% 
confidence level (P value≤0.05). 
2.9. Ethical Issues: 
        -Permission was obtain from the relevant hospitals administrations. 
        -Verbal consent was taken from the child, his parents or caretakers. 
2.10. Research Team: 
• The author, who performed the clinical examination, fulfilled the 
questionnaire and helped some patients to perform unaffordable 
investigations like brain CTscan and MRI. 
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• Ophthalmologist who performed fundus examination for the 
difficult cases. 
• Lab technician 
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Chapter Three 
3. RESULTS 
 
3.1. Demographic characteristic of children in the study 
population: 
3.1.1. Sex Distribution: 
        The study included 103 patients; Males were 63 and females were 40 
patients. Male to female ratio was 1.7: 1. (Figure 1) 
3.1.2. Age Distribution: 
         Thirty five patients (34%) were less than 5 years of age, 32 (31%) 
patients were 5-10 years and 36 (35%) patients were more than 10 years. 
(Figure 2)  
3.2. Pattern of presentation:  
       Figure 3 shows that the commonest presenting symptoms were 
headache in 61 (59.2%) patients, seizures in 51 (49.5%) patients, vomiting in 
48 (46.6%) patients and motor weakness in 40 patients (38.8%).  The least 
presenting symptoms were   paraesthesias in 2 (1.9%) patients, sensory loss 
in 1(1.0%) patient and dysphagia in 1(1.0%) patient. 
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Figure1:The distribution of gender for the study population     
                                                                                                                             
                                                            n=103
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Figure2:The disrtibution of age for the study population    
                                                                                                                              
                                                              n=103
5-10 yr
31%
<5yr
34%
>10yr
35%
 
 
 
 
 52
 
 
 
 
 
 
 
Figure 3: The presenting symptoms in the sudy population              
                                                     n=103
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3.3. Clinical examination: 
        Figure 4 shows that abnormal gait was detected in 44 (42.7%) patients.                  
        Cranial nerves involvement in 45 (43.7%) patients. The commonest 
affected cranial nerve was the optic cranial nerve; this was occurred in 18 
(17.5%) patients mainly with astrocytoma in 11 (61.1%) patients. 
(Table 1) 
       Fundus examination was abnormal in 32 (31.1%) patients ;( optic 
atrophy in 9 (8.7%) patients, papilloedema in 19 (18.5%) patients and both 
optic atrophy and papilloedema in 4 (3.9%) patients and difficult to assess in 
10 (9.7%) patient. (Table 2)     
3.4. Sites of lesions: 
       All patients had brain MRI or brain CT scan, the supratentorial lesions 
were found in 75 (72.8%) patients and infratentorial lesions were found in 
28 (27.2%) patients. (Figure 5) 
3.4.1. Sites of lesions in relation to sex: 
      Table 3 shows that   supratentorial lesions occurred in 50 (66.7%) males 
compared to 25 (33.3%) females. The rest of patients lesions were in 
infratentorial area.  
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Table 1:  Individual cranial nerves involvement in children with 
                 intracranial SOLs in the study population 
                                                                                  
                                                                                                           n=103 
Lesion Cranial Nerves 
 1st 2nd 3rd 4th 5th 6th 7th 8th 9th 10th 11th 12th 
Asrtocytoma  11 1     1     
Abscess  2 2   6       
Medulloblastoma  1 1   1       
Others 1 4 4 1  3  2 1 1 1  
Total 1 18 8 1  10  3 1 1 1  
 
 
  
 Table 2:  Fundal changes in children with intracranial SOLs in the        
                                                              study population 
 
    n=103                       
Funal change Number Percentage 
Papilloedema 19 18.5 
Optic atrophy 9 8.7 
Optic & papilloedema 4 3.9 
Normal 61 59.2 
Difficult to assess 10 9.7 
Total 103 100.0 
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Figure 5: Supratentorial and infratentorial classification for the lesions 
in the study population
                                                           n=103
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Tabe 3:  Sites of lesions (supratentorial and infratentorail) in relation to                          
               sex in the study population      
                                                                                                                
 
                                                                                                                               n=103 
    Supratentorial      Infratentorial            Total Gender 
     No    %     No     %      No     % 
Male 50 66.7 13 46.4 63 61.2 
Female 25 33.3 15 53.6 40 38.8 
Total 75 100.0 28 100.0 103 100.0 
P=0.06 
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      The commonest site of the lesion was the whole cerebellum in 
11(10.7%) patients, the right cerebellum in 6 (5.8%) patients and in the left 
cerebellum is one (1.0%) patient .The lesion was detected in the occipital 
lobe in 9 (8.7%) patients. The least sites affected were occipito temporal 
lobes in one (1%) patient and occipito cerebellar area in one patient (1.0%). 
(Figure 6) 
 3.4.2. Sites of lesions in relation to age group: 
   The commonest site for all age group was the supratentorial area.  <5 years 
28 (37.3%) patients , 5-10 years 23 (30.7%) patients and > 10 years in  24 
(32.0%) patients , this result was statistically insignificant (p=0.4). (Table 4) 
3.4. Sites of lesions in relation to the commonest symptoms and       
signs: 
3.4.3.1. Headache: 
       Table (5) shows that headache was a common symptom with the 
infratentorial lesions detected in 21(75.0%) patients compared to 40 (53.3%) 
patients with supratentorial lesion, this result was statistically significant 
(p=0.04). 
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Figure 6:  Sites for lesions in the study population
                  n=103 
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Tabe 4:  Sites of lesions (supratentorial and infratentorail) in relation to  
               age in the study population                            
 
 
 
n=103 
Supratentoria Infratentorial Total Gender 
No % No % No % 
<5 yr 28 37.3 7 25.0 35 34.0 
5-10 yr 23 30.7 9 32.1 32 31.1 
>10   yr 24 32.0 12 42.9 36 35.0 
Total 75 100.0 28 100.0 103 100.0 
P=0.4 
 
 
Table 5: Headache in relation to sites of lesions in the study population 
                                                                                                            
  n=103 
    Supratentoria      Infratentorial Total Headache
No % No % No % 
Present 40 53.3 21 75.0 61 59.2 
Absent 35 46.7 7 25.0 42 40.8 
Total 75 100.0 28 100.0 103 100.0 
P=0.04 
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3.4.3.2. Vomiting:  
      No significant difference in the symptom of vomiting in relation to the 
site (p=0.6). (Table 6) 
3.4.3.3. Seizures: 
     Forty four (58.7%) patients with supratentorial lesions and 7 (25.0%) 
patients with infratentorial lesions presented with seizures, this relation with 
the sites was statistically significant (p=0.002). (Table 7) 
3.4.3.4. Motor weakness: 
        Twenty six (34.7%) patients from the supratenorial area and 14 (50.0%) 
patients from infratentorial area, presented with motor weakness, the result 
was statistically significant (p=0.00). (Table 8) 
3.4.3.5. Gait disturbance: 
      Gait disturbance was found to be more common with the infratentorial 
lesions than supratentorial lesions, 10 (35.7%) patients  compared to 9 
(12.0%) patients  presented with gait disturbance, this relation was 
statistically significant (p=0.006). (Table 9) 
3.4.3.6. Fundal changes: 
       Papilloedema was the commonest lesion, found mainly in the 
supratentorial lesions in 12 (63.2%) patients compared to 7 (36.8%) patients 
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Table 6: Vomiting in relation to sites of lesions in the study population 
 
                                                                                                              
n=103 
Supratentoria Infratentorial Total Vomiting
No % No % No % 
Present 36 48.0 12 42.9 48 46.6 
Absent 39 52.0 16 57.1 55 53.4 
Total 75 100.0 28 100.0 103 100.0 
P=0.6 
 
  
 
Table 7: Seizures in relation to sites of lesions in the study population  
 
                                                                              
 
n=103              
Supratentoria Infratentorial Total Seizures 
No % No % No % 
Present 44 58.7 7 25.0 51 49.5 
Absent 31 41.3 21 75.0 52 50.5 
Total 75 100.0 28 100.0 103 100.0 
P=0.002 
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 Table 8: Motor weakness in relation to sites of lesions in the study 
             population 
 
 n=103 
    Supratentoria      Infratentorial            Total Motor 
weakness      No    %     No     %      No     % 
Present 26 34.7 14 50.0 40 38.8 
Absent 49 65.3 14 50.0 63 61.2 
Total 75 100.0 28 100.0 103 100.0 
P=0.00 
 
  
 
Table 9: Gait disturbance in relation to sites of lesions in the study        
                  population 
                                                                                                             n=103 
Supratentoria Infratentorial Total Gait 
No % No % No % 
Normal 66 88.0 18 64.3 84 81.6 
abnormal 9 12.0 10 35.7 19 18.4 
Total 75 100.0 28 100.0 103 100.0 
P=0.006  
 
 
 64
 with infratentorial lesions, this result was statistically insignificant 
(p=0.7).(Table 10) 
3.5. Nature of lesions: 
        The nature of lesions was found to be neoplastic in 65 (63.1%) patients 
and non neoplastic in 38(36.9%) patients. (Figure 7) 
Malignant lesions (which were the malignant tumours) were 56 (54.4%) 
lesions and benign lesions (which were tuberculoma, cysts and benign 
tumours) were 47(45.6%) lesions. (Figure 8) 
        The commonest histological lesions were astrocytoma in 36 (35.0%) 
patients, followed by brain abscess in 20 (19.4%) patients and 
Medulloblastoma was detected in 11 (10.7%) patients.  
    Tuberculoma was detected, in 2 (1.9%) patients only. The least lesions 
were found are Adenoma in 1 (1.0%) patient , germ cell papilloma in one 
(1.0%) patient  and epidermoid cyst in 1 (1.0%) patient . (Figure 9) 
3.5.1. Types of lesions (benign and malignant) in relation to      
         Sex: 
         The malignant lesions commonly affected males 34 (60.7%) 
 patients compared to 22  (39.3%) females, the result was statistically in 
significant (p=0.9) .Table(11) 
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 Table 10: Fundal changes in relation to sites of lesions in the study     
                  population 
 
                                                                                                           n=103 
Supratentoria Infratentorial Total Fundal 
finding No % No % No % 
Normal 47 77.0 14 23.0 61 100.0 
Atrophy 6 66.7 3 33.3 9 100.0 
Papilloedema 12 63.2 7 36.8 19 100.0 
Atrophy & 
papilloedema
3 
 
75.0 1 2.0 4 100.0 
Difficult to 
assess 
7 70.0 3 30.0 10 100.0 
Total 75 72.8 28 27.2 103 100.0 
P=0.7 
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Figure 7: Natures of the lesions in the study population    
                                                                                                                             
                                                         n=103
neoplastic
63%
non neoplastic
37%
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Figure 8: Classification of the lesions  into benign and malignant in the 
study population   
                                                                                           n=103
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benign
46%
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Figure 9:Histological types of lesions in the study population     
                                                         n=103
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 Table 11: Types of lesions in relation to sex in the study population 
 
 
 
      n=103 
Benign Malignant Total Type 
No % No % No % 
Male 29 61.7 34 60.7 63 61.2 
Female 18 38.3 22 39.3 40 38.8 
Total 47 100.0 56 100.0 103 100.0 
P=0.9  
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3.5.2. Types of lesions (benign and malignant) in relation to age  
          Group: 
       Table 12 shows that the benign lesions were common among  children < 
5 years 24 patients (51.1%), the malignant conditions were more common 
among children >10 years (42.9%),thiswas statistically significant(p=0.004). 
3.5.3. Types of lesions in relation to sites:  
       Table 13 shows that supratentorial lesions were benign in 41(54.7%) 
patients while infratentorial lesions were malignant in 22 (78.6%) patients, 
this relation was statistically significant (p=0.003).  
3.5.4. Types of lesions in relation to presenting symptoms: 
3.5.4.1. Headache: 
     Table 14 shows that headache was detected in 42 (75.0%) patients with 
malignant lesions compared to 19 patients (40.0%) with benign lesions, this 
relation was statistically significant (p=0.00). 
3.5.4.2. Vomiting: 
     Vomiting was a presenting symptom in 23 (48.9%) patients with benign 
lesions compared to 25 (44.6%) patients with malignant lesions; this result 
was not significant statistically. (Table15) 
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Table 12:  Types of lesions (benign and malignant) in relation to age 
                          in the study population 
 
 
n=103 
Supratentoria Infratentorial Total Age 
group No % No % No % 
<5 yr 24 51.1 11 14.6 35 34.0 
5-10 yr 11 23.4 21 37.5 32 31.0 
>10 yr 12 25.5 24 42.9 36 35.0 
Total 47 100.0 56 100.0 103 100.0 
P=0.004  
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Table 13: Types of lesions in relation to sites in the study population  
  
   
 
      
                                                                                                              n=103 
Supratentoria Infratentorial Total Type of 
lesion No % No % No % 
Benign 41 54.7 6 21.4 47 45.6 
Malignant 34 45.3 22 78.6 56 54.4 
Total 75 100.0 28 100.0 103 100.0 
P=0.003 
  
Table 14: Headache in relation to types of lesions in the study                
                  population 
 
 
     n=103 
Benign Malignant Total Headache
No % No % No % 
Present 19 40.4 42 75.0 61 59.2 
Absent 28 59.6 14 25.0 42 40.8 
Total 47 100.0 56 100.0 103 100.0 
P=0.00 
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Table 15: Vomiting in relation to types of lesions in the study population  
   
 
 
     n=103 
Benign Malignant Total Vomiting
No % No % No % 
Present 23 48.9 25 44.6 48 46.6 
Absent 24 51.1 31 55.4 55 53.4 
Total 47 100.0 56 100.0 103 100.0 
P=0.6  
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 3.5.4.3. Seizures: 
 
      Seizures were detected   in 31(66.0%) patients with benign lesions and in 
20 (35.7%) patients with malignant lesions, this was statistically significant 
(p=0.002). (Table16) 
3.5.4.4. Motor weakness: 
     Table 17 shows that 25 (44.6%) patients with malignant lesions 
presented with motor weakness compared to 15 (31.9%) patients  with 
benign lesions presented with motor weakness, the result was statistically 
insignificant (p=0.18). 
3.5.4.5. Gait disturbance: 
      Table 18 shows that 7 (14.9%) patients with benign lesions   presented 
with abnormal gait compared to 12 (21.4%) patients with malignant lesions, 
this was insignificant statistically (p=0.4). 
3.5.4.6. Fundal changes: 
     Papilloedema was the commonest finding in fundus examination, found 
mainly in the malignant lesions in 11 (57.9%) patients compared to 8 
(42.1%) patients with benign lesions, this was statistically insignificant 
(p=0.06). (Table19) 
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 Table 16: Seizures in relation to types of lesions in the study population 
   
 
     n=103 
Benign Malignant Total Seizures 
No % No % No % 
Present 31 66.0 20 35.7 51 49.5 
Absent 16 34.0 36 64.3 52 50.5 
Total 47 100.0 56 100.0 103 100.0 
P=0.002 
 
  
Table 17: Motor weakness in relation to types of lesions in the study   
         population 
 
 
     n=103 
Benign Malignant Total Motor 
weakness No % No % No % 
Present 15 31.9 25 44.6 40 38.8 
Absent 32 68.1 31 55.4 63 61.2 
Total 47 100.0 56 100.0 103 100.0 
P=0.18 
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Table 18: Gait disturbance in relation to types of lesions in the study 
population                  
 
      n=103 
Benign Malignant Total  
Gait No % No % No % 
Normal 40 85.1 44 78.6 84 81.6 
Abnormal 7 14.9 12 21.4 19 18.4 
Total 47 100.0 56 100.0 103 100.0 
P=0.4 
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Table 19: Fundal changes in relation to types of lesions in the study         
                 population 
 
 
     n=103 
Benign Malignant Total Fundal 
finding No % No % No % 
Normal 28 45.9 33 54.1 61 100.0 
Atrophy 3 33.3 6 66.7 9 100.0 
papilloedema 8 42.1 11 57.9 19 100.0 
Atrophy and 
papilloedema 
0 0 4 100.0 4 100.0 
Difficult to 
assess 
8 80.0 2 20.0 10 100.0 
Total 47 45.6 56 54.4 103 100.0 
P=0.06 
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 3.6. Imaging findings: (Figure 10):  
       The commonest imaging finding were ventricular dilatation in 45 
(43.7%) patients, shifting of the midline in 28 (26.0%) patients and oedema 
in 26 (25.2%) patients, ring enhancement in 19 (18.4%) patients. 
Calcification was found in only 4 (3.9%) patients.  
3.6.1. The commonest imaging findings in relations to sites of 
lesions :( Table 20) 
• Ventricular dilatation: 
         Ventricular dilatation was detected in 35(46.7%) patients with 
supratentorial lesions compared to 13 (46.4%) patients with infratentorial 
lesions, this was statistically insignificant (p=0.9).  
• Shifting of the midline:  
    shows that midline shift was detected in 22 (29.3%) patients with 
supratentorial lesions compared to 4 (14.3%) patients  with infratentorial 
lesions, this result was statistically insignificant (p=0.1). 
• Oedema: 
         Oedma was detected in 19 (25.3%) patients with supratenorial lesions 
and in 7 (25.0%) patients with    infratentorial     lesions, the    result was         
insignificant statistically (p=0.9). 
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Figure10: Imaging findings of patients in the study population
                                                              n=103
 
 
 
 
 
 
 80
 
 
Table 20: The commonest imaging findings in relation to sites of lesions in the study population   
   
 
                                                                                                                                                                                                         n=103 
Supratentorial 
 
Infratentorial Total of the study 
Present Absent Present Absent Total of 
present 
Total of 
absent 
Total 
 
Imaging 
findings 
 
 No % No % No % No % No % No % No % 
Ventricular 
dilatation  
35 46.7 40 53.3 13 46.4 15 53.6 48 46.6 55 53.4 103 100 
Midline shift 
 
 
22 29.3 53 70.7 4 14.3 24 85.7 26 25.2 77 74.8 103 100 
Oedema 
 
 
19 25.3 56 74.7 7 25.0 21 75.0 26 25.2 77 74.8 103 100 
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3.6.2. The commonest imaging findings in relations to types of      
lesions: (Table 21) 
• Ventricular dilatation: 
     Ventricular dilatation was detected in 19 (40.4%) patients with benign 
lesions compared to 26 (46.4%) patients with malignant lesions, this result 
was statistically insignificant (p=0.5).  
• Shifting of the midline:  
       Midline shift was detected in 16 patients (34.0%) with benign lesions 
compared to 10 patients (14.3%) with malignant lesions, this result was 
statistically insignificant (p=0.06). 
• Oedema: 
         Oedma was detected in 13 patients (27.7) with benign lesions 
compared to 13 patients (23.2%) with malignant lesions, this result was 
statistically insignificant (p=0.6).   
3.7. Types lesions in relation to the operative treatment:  
       Seventeen (85.0%) patients with benign lesions were operated while 
only 11(36.7%) patients with malignant lesions were operated, this result 
was statistically insignificant (p=0.6).
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Table 21: The commonest imaging findings in relation to types of lesions (benign and malignant) in the      
                     study population 
                                                                                                                                                                                                           n= 103  
Supratentorial 
 
Infratentorial Total of the study 
Present Absent Present Absent Total of 
present 
Total of 
absent 
Total 
 
Imaging 
findings 
 
 No % No % No % No % No % No % No % 
Ventricular 
dilatation  
 
  
19 
  
40.4 
 
28 
  
59.6 
 
26 
  
46.4 
 
30 
  
53.6 
 
45 
 
43.7 
 
58 
 
56.3 
 
103 
 
100 
 
Midline shift 
 
  
16 
 
34.0 
 
31 
 
66.0 
 
10 
  
17.9 
 
46 
 
82.1 
 
26 
  
25.2 
 
77 
 
74.8 
 
103 
  
100 
  
Oedema 
 
 
13 
 
27.7 
 
34 
  
72.3 
 
13 
  
23.2 
  
43 
  
76.8 
  
26 
  
25.2 
  
77 
  
74.8 
  
103 
 
100 
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3.8. Types of lesions in relation to the Shunt operation: 
       Table 22 shows that 21 (65.6%) patients with malignant lesions had 
ventriculoperitoneal shunt, compared to only 7(35.0%)  patients  with benign 
lesions had the shunt operation, this difference was statistically significant 
(p=0.03).  
 
3.9. Commonest Detected Lesions: 
3.9.1. Astrocytoma: 
          Astrocytoma was the commonest malignant condition detected 
 in 36 (35.0%) children . 
3.9.1.1. Age and sex distribution: 
         There were 5 children (13.9%)   <5 years, 10 children were 5-10 years 
(27.8%) and 21 children (58.3%) were > 10 years. 
         Males were 19 patients (52.8%) and females were 17 patients (47.2%). 
3.9.1.2. Clinical presentation: (Figure 11) 
        The commonest presentation were headache in 27 (75.0%) patients, 
visual impairment  in 19 (52.8%) patients and unsteadiness was found in 18 
(50.0%) patients. 
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Table 22: The relation between types of lesions and the V.P shunt         
                 operation in the study population 
n=52 
Benign Malignant Total Shunt 
operation No % No % No % 
present 7 35.0 21 65.6 28 53.8 
Absent 13 65.0 11 34.4 24 46.2 
Total 20 100.0 32 100.0 52 100.0 
P=0.03 
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Figure11:The presenting symptoms of patients with Astrocytoma    
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3.9.1.3. Clinical examination: (Figure 12) 
       The commonest clinical finding was hyporeflexia in 13 (36.1%) 
patients, abnormal gait (mainly ataxia) in 12 (33.3%) patients and cranial 
nerve involvement was detected in 12 (33.3%) patients. 
 Fundus examination revealed that 8 (22.2%) patients had optic atrophy, 8 
(22.2%) patients had papilloedema. 
3.9.1.4. Imaging findings: 
        The lesions were detected in supratentorial and infratentorial equally, 
18 (50.0%) patients. The commonest site for astrocytoma was the 
cerebellum in 17 (47.2%) patients. The commonest lesion found in the 
cerebellum was astrocytoma compared to other types of lesions, this result 
was statistically significant (p=0.001).The lesion was parietal in 5 (13.9%) 
patients, temproparietal in 5(13.9%) patients. (Figure 13)  
        Shifting of the midline was detected in 8 (22.2%) patients ,oedema was 
found in 10 (27.8%) patients .In precontrast  study there were 6 (16.7%) 
lesions showed  hypodense , 5 (13.9%) lesions showed hyperdense and 9 
(25.0%) lesions showed mixed nature . Five (13.9%) lesions showed ring of 
enhancement. Ventricular dilatation was detected in 16 (44.4%) patients .In 
contrast study 13 (36.1%) patients showed mixed feature and 11  (30.6%) 
patients  showed hypodense lesions. 
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                                           n=36
 
 
  
 
 
 
 89
 3.9.2 Abscess: 
          Abscess was found in 20 patients (19.4%). 
3.9.2.1. Age and sex distribution:   
        There were 9 (45.0%) patients below the age of 5 years , 5 (25.5%) 
patients between 5-10 years  and 6 (30.0%) patient were above 10 years of 
age  .  They were 13(65.0%) male (65.0%) and 7(35.0%) female.  
3.9.2.2. Clinical presentation:  
       The commonest presenting symptoms were seizures in 16(80.0%) 
patients, vomiting in 11(55.0%) patients, fever in 11(55.0%) patients and 
headache in 10 patients. (Figure 14)   
3.9.2.3. Clinical examination: 
        Cranial nerves involvements were detected in 5 (25.0%) patients. 
Fundal examination detected 6 (30.0%) patients with papilloedema and 2 
(10.0%) patients with optic atrophy. (Figure 15)  
3.9.2.4. Imaging findings: 
         The lesions were detected in supratentorial in 18 (90.0%) patients. The 
commonest sites were parietal lobes in 9 (45.0%) patients, frontal lobes in 5 
(25.0%) patients and temporal lobes in 3 (15.0%) patients. (Figure16) 
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        Midline shift was detected in 6 (30.0%) patients, oedema was detected 
in 14(70.0%) patients, this relation was statistically significant (p=0.00). 
      Ring of enhancement was found in 10(50.0%) patients, the result was 
statistically significant (p=0.00).Ventricular dilatation was detected in 9 
(45.0%) patients .Contrast enhancement showed hypodense lesions in 6 
(50.0%) patients. 
 
3.9.3. Medulloblastoma : 
           Medulloblastoma was detected in 11(10.7%) patients. 
3.9.3.1. Age and sex: 
         There were 3 (27.3%) children below age of 5 years, 6 (54.5%) 
children between 5-10 years and 2 (18.2%) children their age above 10 
years. 
       The males were 9 (81.8%) patients and the females were 2 (18.2%) 
patients. 
3.9.3.2. Clinical presentation: 
        The commonest presenting symptoms were vomiting which was 
detected in 9 (81.8%) patients, headache in 8 (72.0%) patients and motor 
weakness in 7 (63.6%) patients. (Figure 17) 
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3.9.3.3. Clinical examination:  
       Cranial nerves involvements were found in 4 (36.4%) patients. 
Papilloedema was detected in 2 (18.2%) patients. (Figure 18) 
3.9.3.4. Imaging findings: 
       The lesion was in the cerebellar vermis in 7 (63.6%) patients occipital in 
2 (18.2%) and in the 4th ventricle in 2 (18.2%) patients. (Figure 19) 
       Midline shift and ring of enhancement were not detected in this lesion 
while odema was detected in only 1 (9.1%) patient .Ventricular dilatation 
was found in 2 (18.2%) patients    and contrast enhancement showed mixed 
lesions in 4 (66.6%) patients. 
 
3.9.4. Other intracranial space occupying lesions: Table (23) 
        The commonest presenting symptom in the cystic lesions (arachnoid 
cyst and dermoid cyst) was increased the size of the head, in (57.1%) of 
arachnoid cyst patients and in (60%) of dermoid cyst patients. This relation 
was statistically significant (p=0.04). Cranial nerves lesions were the 
commonest findings in most of the lesions. Tuberculomas were detected in 
only 2 (1.9%) patients. 
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 Table 23: Other histological types of lesions in intracranial SOLs in the 
                  study population   
 
Lesion Age Symptom sign Number percentage 
Arachnoid cyst <5 yr Increase head 
size 
Cranial 
nerves lesion 
7 6.8 
Dermoid  cyst <5 yr Increase head 
size 
Cranial 
nerve lesion 
5 4.9 
Meningioma All age Seizures Cranial 
nerves lesion 
3 2.9 
Epindymoma < 5yr Headache 
Vomiting 
seizures 
Cranial 
nerves 
lesions 
 
4 
 
3.9 
Cranipharyngioma 5-10 Headache 
Vomiting 
Seizures 
Cranial 
nerves 
lesions 
 
5 
 
4.9 
Tuberculoma  Headache Motor 
weakness 
2 1.9 
Hydatid cyst  Seizures Motor 
weakness 
2 1.9 
papilloma  Vomiting Cranial 
nerves lesion 
2 1.9 
Oligodendroglioma    1 1 
Epidermoid cyst    1 1 
Adenoma    1 1 
Germ cell    1 1 
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3.9.5. Other lesions detected: 
          Congenital heart disease was detected in 5 (4.8%) patients, 2 (1.9%) 
patients had central precocious puberty, one (0.9%) patient had dextrocardia,  
one (0.9%) patient had mitral valve disease , one  (0.9%) patient had 
Dandywalker disease  and one (0.9%) patient had sickle cell disease ,one 
(0.9%) patient had meningomyelocele. (Table 24)  
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 Table 24: Other lesions detected with intracranial cranial SOLs in the     
                                                             study population     
 
Lesion Number Percentage 
Central precious puberty 2 1.9 
Congenital H.D 5 4.8 
Dandy walker 1 0.9 
Dextrocardia 1 0.9 
Mitral valve lesion 1 0.9 
Meningiomyelocele 1 0.9 
Sicke cell disease 1 0.9 
Total 12 11.2 
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Chapter Four 
DISCUSSION 
 
          The study included 103 children with predominance of males, male to 
females ratio was 1.7:1. This is comparable to that reported in literature (1) 
and this result is comparable also to the study by Ifran  in Karachi who 
reported that male : female ratio was 1.6:1(93). This can be explained by the 
fact that most of SOLs are predominating in males. Although the age groups 
were divided into three groups generally no apparent differences in the 
distributions were found, (less than 5 years were 34%, between 5-10 years 
were 31% and > 10 years were 35%). So all age groups were affected, this 
result may be explained by the fact that many pathologies were included in 
the SOLs.  
         The most common presentations were that of increased intracranial 
pressure, this was in agreement with Desai result in India, mentioning that 
the commonest presentations were symptoms of increased intracranial 
pressure (11). Headache was the commonest presenting symptom (59.2%) but 
did not occur in all patients and this goes with literature mentioning that 
headache is common but not invariable(16) , this is  more than Sanchez result 
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which reported that only 3 (3.2%) children out of 94 children presented with 
headache necessitated hospital admission had intracranial space occupying 
lesions (94).   
        The next common presenting symptom was   seizures  in 51 (49.5%) 
patients and it seems to be higher in our study compared to Mustafa  result 
(29) who found that  vomiting was found in (46.6%) and seems to be similar 
to that reported in literature(1), however Sanchez  in his study mentioned that 
vomiting was accompanying symptom in 38.2% (94). Motor weakness was 
found in 40 (38.8%) cases, which also was found to be significant. The 
presence of fever in 26.2% of patients can be explained by the fact that 
abscesses constituting a significant proportion of SOLs in this study19.4% 
could be responsible for the fever.              
         Increased in the size of the head was found in 21% can be explained by 
the fact that the study included  patients below 2 years of age which were 19 
(18.5%) patients , this increase in the size due to opened sutures in those 
children. 
         Abnormal gait was present in (42.7%) and more common with 
infratentorial lesions, a possible cause of this result is that the cerebellar 
involvement is common in this study so many patients presented with 
abnormal gait mainly ataxia. Cranial nerves involvement occurred in 
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(39.8%) and the commonest nerve to be affected is the 2nd followed by the 
3rd then 6th table(2) ,  Wanyoike reported that 20% of his cases were blind at 
the time of presentation (6).The commonest finding in the optic fundi was 
papilloedema (16.6%),followed by optic atrophy which was present in 
(7.8%), compared to Mustafa , who studied intracranial SOLs in adults in 
118 patients he found the same order of the lesions(29)  .  
           Supratentorial lesions were more common than infratentorial lesions 
this can be explained by the fact that this study included all lesions not only 
tumours which are more common infratentorial in children (13). The 
cerebellum was the commonest site for tumuors, mainly astrocytoma that in 
keeping with literature (3), however Desai mentioned that the commonest site 
in the cerebellum was the vermis (11). The next common site is the occipital 
region (8.7%). These findings are not comparable to that reported by 
Mustafa , that the commonest location was temproparietal(29) , however his 
study confined to adults, also Abu Salih and Abdul Rahman reported the 
commonest site was frontal(6) , their study was confined to patients with 
brain tumours. 
         Supratentorial lesions were found to be commonly benign in 
41(54.7%) children compared to infratentorial lesions which were 
commonly malignant in 22 children (78.6%), this may be due to that fact 
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that most of tumours confined to infratentorial area while most of abscess 
and cysts confined to supratentorial. 
        The benign conditions were found to be commonly below 5 years, this 
because of increased incidence of the congenital cysts. The malignant 
conditions increased with age and common in male more than female, this in 
keeping with Hoffman study mentioned that there is increasing incidence of 
primary brain tumors over the past few decades. Data for the years 1985 
through 1999  were used to determine incidence trends in the broad age 
groups 0-19, 20-64, and >or=65 years, he concluded that incidence increased 
modestly. When brain lymphomas were excluded, this increase remained 
statistically significant, increases that were not specific to any population 
subgroup were seen for oligodendrogliomas, ependymomas, meningiomas, 
and nerve sheath tumors (95). 
        Astrocytoma was found to be the commonest intracranial SOL 35% and 
it was the most common primary brain tumour. These findings are 
comparable to those in literature(3),Ifran  in Karachi mentioned that the 
commonest lesion in his study was astrocytoma that comprised 32.1% of the 
total cases (386 patients) followed by meningioma (13.7%), however Abu 
Salih and Abdul Rahman found that meningioma was the commonest brain 
tumour(6)  .The age group >10 years affected more common (58.3%) 
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followed by age group5-10 years (27.8%) then the age group <5 years 
(13.9%), this result can be explained by the fact that there is increase 
incidence of brain tumours(96).Males were affected more commonly than 
females (52.8%) this is in keep with literature also Mustafa  concluded the 
same result(29) but in consistent with Wanyoike result mentioning that female 
affected more that male (9). 
           The commonest symptom was headache (75%), in view of different 
reports in literature about occurrence of headache in astrocytoma and 
gliomas in general , headache in this study seems to be higher than that 
reported by Abu Salih and Abdul Rahman(6), but less than that reported by 
Mustafa  (29)    .The next commonest symptoms were vomiting and seizures in 
(30.6%) , the result of vomiting was comparable to Mustafa  result (32.2%) 
but seizures seems to be less than that reported by Mustafa SA (51.6%) (29) 
this can be explained by the fact that most of astrosytoma in our study was 
confined to the cerebellum not to lobes where there are increase risk of 
irritation and so to seizures, this result was not similar to Wanyoike reported 
that cerebellar symptoms were the most common mode of presentation 
(30%) followed by headaches and vomiting  and no seizures this because the 
lesions were in the posterior fossa (9).The relationship between head trauma 
and astrocytoma statistically insignificant, however many patients related 
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their headache to a history of head trauma. Cranial nerves involvement was 
evident in (33.3%) which is less than that reported by Mustafa (41.9) (29), it 
was mentioned in literature that Posterior fossa lesions carry a high risk of 
obstructive hydrocephalus, cranial nerves palsy and brain stem compression 
pituitary and chiasmatic tumors a risk of blindness(97), the commonest  
affected cranial nerve in this study was the 2nd  Mustafa reported that the 
commonest affected cranial nerve was the 7th (29) .Papilloedema and optic 
atrophy were equally detected (22.2%) .Ataxia was detected in (33.3%) this 
may be due to the fact that most of astrocytoma in our study was in the 
cerebellum(30.6%) , these comparable with literature(3) reported that ataxia is 
often associated with posterior fossa tumours although sometimes large 
tumours can cause no abnormalities in movement , this result is higher than 
that reported by Mustafa (12.9%) . 
      Shifting of the midline in astrocytoma in imaging was detected in 
(22.2%), while odema was found in 27.8%. Most of astrocytomas were 
mixed lesions in this study (36.1%), some hypodense (30.6%) and this 
finding is different from literature mentioned that astrocytoma more 
common hypodense lesions (98), Mustafa reported that the commonest 
attenuation was hypodense lesions (29),Vaghi  mentioned that forty surgically 
proved gliomas have been studied by MRI: 21 were low-grade gliomas and 
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19 were anaplastic astrocytomas and glioblastomas. MRI findings were 
similar in low-grade and anaplastic astrocytomas, but quite different from 
imaging of glioblastomas. Tumoral cyst and areas of necrosis were 
recognized on MRI studies and confirmed by surgical findings. 
Differentiation between tumour and oedema was difficult (99). 
        Brain  abscess constituted (19.4%) of all intracranial SOLs. It was the 
second common SOL. It affected mostly those in the age group<5 years 
(45.0%) which can be explained by increase incidence of congenital heart 
disease, sickle cell disease and otitis media at these age, followed by those in 
age group>10 years (30.0%) then (25.5%) in age group 5-10 years, this 
incomparable with literature in which abscess more common in age group 5-
10 years(3). Males were predominantly affected (65.0%), this in keeping with 
literature reporting that abscess is 2 to 3 times common in males(13) , this also 
in consistent with Mawag result mentioning that males are more affected but 
he mentioned that the common cause for brain abscess in his study was 
trauma (10). 
       The commonest symptom were seizures (80.0%) followed by vomiting 
and fever in (55.0%) , headache was found in (50%), this is not comparable 
to literature stating that headache and fever are the commonest presenting 
symptoms (3) , this can be explained by the fact that most of our patients < 5 
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years(45.0%) had increase incidence of congenital heart disease and otitis 
media which commonly affect the temporal lobe so cause cortical irritation 
which lead to seizures, another explanation is that seizures are more 
detectable in young children by mothers than fever. Motor weakness was 
found in (40%), unsteadiness in (25%). Cranial nerves involvement were 
detected in (25%),this is less than that reported by Mustafa  where cranial 
nerves involvement in (50%) of his cases(29), the most affected cranial nerve 
was the 6th .Papilloedema was detected in (30%) and optic atrophy in 
(10%),in Mustafa SA study papilloedema was detected in (33.3%)(29).  
         Commonly the abscess was located in parietal in (45.0%), frontal in 
(25.0%) and temporal in (15.0%), this is comparable with literature which 
mentioned that (80.0%) of abscesses were divided between the frontal, 
parietal and temporal areas (3). 
       Hypodense lesion and ring enhancement were found in (50.0%). 
Mustafa reported that all abscesses in his study showed hypodense lesion 
and all had ring of enhancement (100.0%) (29). 
 Oedema was detected in (60.0%) of cases which statistically significant 
(p=0.00). 
      Congenital heart diseases was a risk factor in (4.8%) which may added to 
the risk factors for brain abscess, Mehnaz A in Pakistan in his study found 
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that cyanotic congenital heart disease was a predisposing factor in 11 
children(37%) out of 30 children (100). 
           Medulloblastoma accounts for (10.7%) of all cases and the second 
common brain tumour in the study, it was mentioned that astrocytoma and 
medulloblastoma are more common in children than the other types of 
tumours(3). The commonest age group between 5-10 years (54.5%) this result 
comparable with literature reported that medulloblastoma is the most 
prevalent brain tumours in children less than 7 years (3), followed by <5 years 
(27.3%) then >10 years (18.2%), it was mentioned in literature that 
medulloblastoma uncommon in adults, i.e. 20 years of age(101). 
         Males were commonly affected (81.8%), and females were 
(18.2%),this result comparable with the literature mentioned that males  
more commonly affected than females(101), however  Wanyoike reported that 
Medulloblastoma in his study a predominantly female tumour as opposed to 
available literature(9).  
          Clinical presentation was dominated by raised ICP, thus vomiting was 
the commonest presenting symptoms (81.8%), then headache in 72.0% it 
was mentioned that no specific symptoms and  signs for medulloblastoma 
and headache and vomiting was due the  hydrocephalus result rather than the 
mass it self (101). 
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             Cranial nerves involvement was found in (27.3%), the affected 
cranial nerves were the 2nd, 3rd and 6th cranial nerve. Papilloedema was 
detected in (18.2%).  
       Medulloblastoma was found to be more commonly infratentorial which 
was comparable which literature (101) mentioning that medulloblastoma is a 
typically posterior fossa tumour but can metastasize by CSF. The 
commonest site was cerebellar vermis in (63.6%), 4th ventricle is the second 
common place in (18.2%), literature mentioned that medulloblastoma can 
originate from the roof of the 4th ventricle and grows rapidly to fill the 4th 
ventricle (3). Contrast enhancement was mixed in (66.6%) this result was 
uncomparable with literature mentioning that the common appearance is the 
hyperdense a feature that  can differentiate it from from astrocytoma (101) 
however Mueller mentioned that medulloblastoma can have a typical 
features included cyst formation in (77%) of his cases who were 13 patients 
and   mixed    enhancement  in (14%) (95). 
        Arachnoid  cyst  accounted for (6.8%) of all cases, this was higher than 
that reported in literature which reported only (1%) of all SOLs (70) and 
higher than Mustafa result where reported (2.5%) of al intracranial SOLs. 
The commonest age group was below 5years (85.7%), this was comparable 
with literature and this due to the fact that it is a congenital lesion .Males 
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were affected more (57.1%). The commonest presenting symptom was 
increase the size of the head (57.1%) which comparable with literature (70) 
.Seizures were detected higher in our study (57.1%) than that mentioned by 
Gomez  in his study (25.7%) (70). Cranial nerves lesion was detected in 
(28.6%).  
       The commonest site for the lesion was temporal in (49.2%), this result 
was comparable with literature (101) then frontal in (28.6%).Midline shift and 
ventricular dilatation were detected in (42.8%).  
         Dermoid cyst was detected in (4.9%) of all cases, All the cases below 5 
years. Male were commonly affected (60%). The commonest presenting 
symptoms are those of increase intra cranial pressure (increase size of the 
head and vomiting) in (60.0%), in literature it is reported that dermoid cysts 
can be space-occupying masses because of increasing CSF retention, which 
may be due to a ball-valve mechanism or to inadequate communication,the 
frequently associated hydrocephalus, can be due to mechanical factors(77) . 
        Meningioma was detected in (2.9%) of all cases, Abu Salih and Abdul 
Rahman found that meningioma was the commonest brain tumour in their 
study; this was true for adult population (6). 
         Age distribution was equal in all age group (33.3%) and males were 
affected more (66.7%) this not in keep with literature that mentioned females 
 112
are common affected than males (13), but this may be due to the small size of 
the affects only 3 patients. 
          Ependymoma accounts for (3.9%) for all cases of SOLs. The 
commonest age group was below 5 years (75.0%),this result goes with 
literature mentioning that it is more common in young children(101). males 
and females were equally affected. The commonest presenting symptoms 
were headache, vomiting and seizures (50%). Cranial nerves lesion was 
detected in (50.0%). The commonest site was occipital in (50.0%) which 
was incomparable with literature which mentioned the 4th   ventricle as the 
common site (101); this difference may be due to the small size of patients.  
        Craniopharyngioma was detected in (4.9%) of all cases. The 
commonest age group was between 5-10 years (60.0%), which was 
comparable with literature (101). Headache and vomiting were the commonest 
presenting symptoms in (80.0%), this result was different from the study 
mentioned that visual deficits and endocrine dysfunctions are the most 
frequent presenting symptoms(101),however children frequently presented 
with symptoms of increased intracranial pressure. 
         The commonest sites for the lesion were occipital and suprasellar in 
(40.0%) and occupied both sellar and supra sellar regions in (20.0%), this 
was comparable with literature which mentioned sellar and supra sellar as 
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commonest sites (3). Calcification was detected in (80.0%) of cases and it was 
found to be significant as mentioned in literature (3). 
        Although tuberculosis was a common endemic disease in our country, it 
seems to be that brain tuberculoma is underdaignosed (1.9%), Ramamurthi 
mentioned that tuberculomas of the brain in children constitute 5% to 8% of 
intracranial space occupying lesions in developing countries, the image 
morphology of tuberculoma could simulate other lesions like gliomas (96). 
      Two patients (1.9%) had hydatid cysts, this result comparable with 
literature mentioned that the incidence of hydatid is (2%) (12) and (1%) (83) in 
another source , however Mustafa  reported higher result (2.5%). In the 2 
patients no evidence of extracranial  hydatid cyst was detected. 
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CONCLUSION 
 
? Different types of intracranial SOLs were identified. Neoplastic 
conditions accounts for the majority of all intracranial SOLs. 
? The commonest intracranial SOL was astrocytoma followed by 
abscess and medulloblastoma. 
? Intracranial SOLs are more common in males and all age groups are 
affected. 
? The commonest clinical presentations were that of raised intracranial 
pressure, headache and vomiting seem to be important signs for 
serious problems. 
? Intracranial SOLs   commonly located supratentorial , while tumours 
commonly located infratentorially mainly the cerebellum. 
? The benign conditions were more common in age group <5 years and 
the malignant conditions were more common in age group <10 years. 
? Malignant lesions commonly affected males. 
? Benign conditions more operable than the malignant conditions and 
malignant lesions more needed for ventriculoperitoneal shunts.  
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? Incidence of tuberculoma was found to be less than expected therefore 
a high index of clinical suspicion in addition to proper investigations 
for tuberculosis should be considered. 
? Some associated diseases were detected which may need further 
studies. 
? Imaging studies were helpful in detecting the lesions and their 
secondary effects. In some lesions the finding has a high validity. 
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RECOMMENDATIONS 
 
 
 
?  Simple complaint like headache and vomiting must be considered and 
appropriately evaluated.  
? Proper history taking and proper examination should be executed   to 
detect the symptoms and signs of the intracranial space occupying 
lesions early enough to offer better opportunity for better outcome. 
? Imaging techniques should be utilized early in the presentation;   MRI 
might offer better chance for detection of lesions at an early stage.  
? Early interactions to relief   the increased   I.C.P by placement of V.P 
shunts.  
? There is a need for performing more biopsies for reaching the final 
diagnosis in accessible tumours. 
? Emphasis on diagnosis of SOL in undergraduate curricular and CPD 
courses for general practitioners stressing the importance of early 
referral. 
? Decentralization of services by establishment of regional diagnostic 
centers and specialized team.   
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? Training more paediatrics neurologists, neurosurgeons and 
radiologists to deal with cases in the district hospitals. 
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Questionnaire 
 
 CLINICAL PATTERN AND IMAGING FINDINGS OF 
INTRACRANIAL SPACE OCCUPYING LESIONS IN CHILDREN 
 
 
 
 
Name ……………         Age    …………….                                        Sex …………… 
 
Residence…………….                                                                         Tribe…………… 
 
 
General Symptoms: 
 
• Headache                                   yes                                                   no 
 
• Vomiting                                     yes                                                  no 
 
• Nausea                                        yes                                                  no 
 
• Seizures                                       yes                                                 no 
 
• Fever                                            yes                                                 no 
 
• Loss of consciousness                 yes                                                 no 
 
• Neck stiffness                              yes                                                 no 
 
• Mental symptom(specify)            yes                                                no 
 
• Increase size of the head               yes                                               no 
 
Sensory symptoms: 
 
• Loss                                             yes                                               no              site... 
 
• Paraesthesias                                yes                                              no             site… 
 
Motor symptoms: 
 
• Unsteadiness                              yes                                              no            s  site… 
 
 
 
 
• Tremors                                          yes                                             no            site.. 
 
• Stiffness                                          yes                                            no             site.. 
 
• Motor weakness                              yes                                           no             site… 
 
Symptom due to cranial nerve involvement: 
 
• Anosmia                                                  yes                                 no 
 
• Visual impairment                                   yes             (specify)     no                 
 
• Diplopia                                                   yes                                no 
 
• Squint                                                       yes                                no 
 
• Deviation of the mouth                             yes                               no 
 
• Deafness                                                    yes                               no 
 
• Dysphagia                                                   yes                              no 
 
Other symptoms: 
 
• Speech disturbance                                     yes                               no 
 
• Behavioral changes                                     yes            (specify)     no 
 
• Incontinence                                                yes                               no 
 
• Gait disturbance                                          yes             (specify)     no            
 
Past medical history: 
 
• TB                                                               yes                               no 
 
•   Trauma                                                       yes                             no 
 
• Epilepsy                                                        yes                            no 
 
• Otitis media                                                   yes                            no 
 
 
 
 
• Sinusitis                                                         yes                            no 
 
• Schistosomiasis                                              yes                           no 
 
 
Family history: 
 
           Similar disease                                                     yes                        no         
 
                          Who………. 
 
     Other disease                                                      yes                        no           
 
     What……..                                             who………….. 
 
Drug history: 
 
 
Physical examination:- 
 
Wt………………….        Ht………….                               Hc……. 
 
 
? Fever                                                      yes                              no 
 
? Pallor                                                        yes                            no 
 
? Jaundice                                                    yes                            no 
 
? Lymph node                                              yes                           no 
 
 
i. CVS                                          normal                    abnormal 
 
 
ii. RS                                             normal                    abnormal 
 
 
iii. Abdomen                                   normal                   abnormal 
 
 
 
 
 
iv. Skin condition                           normal                    abnormal 
 
v. Nervous system:- 
 
 
• Oriented                         yes                            no 
 
• Dementia                        yes                           no 
 
• Confused                        yes                           no  
 
 
• Motor dysphasia             yes                          no            
 
                                                        
• Comatosed                       yes                           no 
 
• GCS………………… 
 
 
• Cranial nerve lesions:  
    R: 
 
              L: 
 
Fundoscopy: 
• R:               normal                            abnormal                     specify……….. 
 
• L:               normal                            abnormal                      specify……… 
 
 
? Neck: 
 
• Neck stiffness              yes                                   no 
 
 
• Weakness of flexor       yes                                   no 
 
 
• Weakness of extensor    yes                                  no 
 
 
 
 
 
 
 
 
 
? Limbs: 
   
R L R L 
Wasting     
Fasiculation     
Tone     
Power(grade)     
 
 
 
 
Note: increased=3    normal=2   redused=1 
 Reflexes 
Biceps  
Triceps  
Supinator  
Knee  
Anckle  
 
 
Sensation: 
 
Touch  
Pinprick  
Temperature  
Vibration  
Position  
 
 
? Abdominal reflexes  
 
 
 
 
 
 
? Planter reflex………..( R)………….(L)………………. 
 
? Coordination             (R)      ………..(L)……………R=L R<L R>L 
 
? Gait                    normal                                         abnormal              specify……. 
 
? The back            normal                                         abnormal             specify……. 
 
? Skull                  normal                                         abnormal             specify……..   
 
 
 
 
 
Investigation: 
 
CBC…………………………………. 
………………………………………………………………………………… 
………………………………………………………………………………….. 
RFT……………………………………………………………….. 
………………………………………………………………………. 
LFT…………………………………………………….. 
………………………………………………………………………………. 
Skull X-ray…………………………………………………………….. 
 
MRI:………………………………………………………………………………………
………………………………………………………………………………………………
………………………………………………………………………………………………
…………………………………………………………………………………………….. 
 
Brain CT scan…………………………………….. 
………………………………………………… 
……………………………………………………………….. 
…………………………………………………………………………. 
…………………………………………………… 
Abdomenal U/S……………………………… 
…………………………………………………………………… 
……………………………………………………. 
Histopathology………………………………………………………………………… 
…………………………………………………………………………………………… 
…………………………………………………………………………………….. 
Other investigations:………………………………………………………………….. 
………………………………………………………………………………….. 
…………………………………………………………………………..; 
 
 
Treatment: 
 
 
 
a) Medical         (specify)………………………………… 
……………………………………………………………………… 
……………………………………………………………………………………….. 
……………………………………………………………………………………………… 
     b)   Surgical            (specify)…………………………………………………………….      
…………………………………… 
 
